CAMKK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| O00151 | T94 | Sugiyama | PDLIM1 CLIM1 CLP36 | TDNLtLtVARsEHKVWsPLVtEEGKRHPYKMNLASEPQEVL |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O14950 | T128 | Sugiyama | MYL12B MRLC2 MYLC2B | ACFDEEATGTIQEDYLRELLttMGDRFtDEEVDELyREAPI |
| O14950 | T129 | Sugiyama | MYL12B MRLC2 MYLC2B | CFDEEATGTIQEDYLRELLttMGDRFtDEEVDELyREAPID |
| O14950 | T160 | Sugiyama | MYL12B MRLC2 MYLC2B | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| O43399 | T146 | Sugiyama | TPD52L2 | yKKTQETLsQAGQKtsAALstVGsAIsRKLGDMRNsAtFKs |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O95373 | T968 | Sugiyama | IPO7 RANBP7 | IIDDEDNPVDEYQIFKAIFQtIQNRNPVWyQALTHGLNEEQ |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P04040 | T29 | Sugiyama | CAT | SDQMQHWKEQRAAQKADVLttGAGNPVGDKLNVItVGPRGP |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | T223 | Sugiyama | ANXA1 ANX1 LPC1 | ARALyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKY |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | T174 | Sugiyama | HSPB1 HSP27 HSP28 | SSsLsPEGtLTVEAPMPKLAtQsNEItIPVtFEsRAQLGGP |
| P05198 | T281 | Sugiyama | EIF2S1 EIF2A | KIEEKRGVFNVQMEPKVVtDtDEtELARQMERLERENAEVD |
| P05387 | S29 | Sugiyama | RPLP2 D11S2243E RPP2 | LAALGGNssPsAKDIKKILDsVGIEADDDRLNKVIsELNGK |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06744 | T248 | Sugiyama | GPI | WFLQAAKDPSAVAKHFVALstNttKVKEFGIDPQNMFEFWD |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07237 | T453 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | EAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKFLESG |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07814 | T746 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | NETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVRE |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | T94 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KELHINLIPNKQDRtLtIVDtGIGMTKADLINNLGtIAKSG |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | T401 | Sugiyama | SLC3A2 MDU1 | NSSDLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQ |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08865 | T94 | Sugiyama | RPSA LAMBR LAMR1 | VsVIssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQA |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | S54 | Sugiyama | TUBA3C TUBA2 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P10809 | S453 | Sugiyama | HSPD1 HSP60 | EEGIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLK |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P12277 | S164 | Sugiyama | CKB CKBB | PHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAEQ |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P14618 | T195 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | yVDDGLISLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAA |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17980 | T163 | Sugiyama | PSMC3 TBP1 | EKLKPGDLVGVNKDSyLILEtLPtEyDsRVKAMEVDERPtE |
| P19105 | T127 | Sugiyama | MYL12A MLCB MRLC3 RLC | ACFDEEATGTIQEDYLRELLttMGDRFtDEEVDELyREAPI |
| P19105 | T128 | Sugiyama | MYL12A MLCB MRLC3 RLC | CFDEEATGTIQEDYLRELLttMGDRFtDEEVDELyREAPID |
| P19105 | T159 | Sugiyama | MYL12A MLCB MRLC3 RLC | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| P20290 | T182 | Sugiyama | BTF3 NACB OK/SW-cl.8 | LRRLAEALPKQsVDGKAPLAtGEDDDDEVPDLVENFDEAsK |
| P23284 | T81 | Sugiyama | PPIB CYPB | IFGLFGKTVPKTVDNFVALAtGEKGFGYKNSKFHRVIKDFM |
| P23381 | T362 | Sugiyama | WARS1 IFI53 WARS WRS | ALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFsGGRD |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | S53 | Sugiyama | CALR CRTC | WtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDAR |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P30041 | T48 | Sugiyama | PRDX6 AOP2 KIAA0106 | FLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKL |
| P30043 | T191 | Sugiyama | BLVRB FLR SCAN | GPSRVISKHDLGHFMLRCLttDEyDGHstyPsHQyQ_____ |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30626 | T130 | Sugiyama | SRI | IsFDTDRSGTVDPQELQKALttMGFRLsPQAVNSIAKRYst |
| P30626 | T131 | Sugiyama | SRI | sFDTDRSGTVDPQELQKALttMGFRLsPQAVNSIAKRYstN |
| P31749 | T308 | EPSD|PSP | AKT1 PKB RAC | IKITDFGLCKEGIKDGAtMKtFCGtPEyLAPEVLEDNDyGR |
| P33176 | S950 | Sugiyama | KIF5B KNS KNS1 | PAAsPtHPSAIRGGGAFVQNsQPVAVRGGGGKQV_______ |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P35241 | S533 | Sugiyama | RDX | ERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHAE |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40227 | S49 | Sugiyama | CCT6A CCT6 CCTZ | GLQDVLRTNLGPKGTMKMLVsGAGDIKLTKDGNVLLHEMQI |
| P42677 | S11 | Sugiyama | RPS27 MPS1 | __________MPLAKDLLHPsPEEEKRKHKKKRLVQsPNsy |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | S180 | Sugiyama | NAMPT PBEF PBEF1 | TVATNSREQKKILAKyLLEtsGNLDGLEyKLHDFGyRGVSS |
| P46777 | T177 | Sugiyama | RPL5 MSTP030 | NKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRK |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49327 | T1150 | Sugiyama | FASN FAS | ERAALQEELQLCKGLVQALQtKVTQQGLKMVVPGLDGAQIP |
| P50990 | S373 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | SEVGDTQVVVFKHEKEDGAIstIVLRGstDNLMDDIERAVD |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P51149 | T168 | Sugiyama | RAB7A RAB7 | NIPyFEtSAKEAINVEQAFQtIARNALKQETEVELyNEFPE |
| P54646 | T172 | GPS6|SIGNOR|EPSD|PSP | PRKAA2 AMPK AMPK2 | NAKIADFGLSNMMsDGEFLRtsCGsPNyAAPEVISGRLYAG |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60660 | T85 | Sugiyama | MYL6 | LDFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVM |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P61163 | T101 | Sugiyama | ACTR1A CTRN1 | KDWNDMERIWQYVYSKDQLQtFSEEHPVLLtEAPLNPRKNR |
| P61163 | T111 | Sugiyama | ACTR1A CTRN1 | QYVYSKDQLQtFSEEHPVLLtEAPLNPRKNRERAAEVFFET |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | T70 | Sugiyama | HNRNPK HNRPK | QSKNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsI |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62899 | T107 | Sugiyama | RPL31 | RLSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN__ |
| P62899 | T119 | Sugiyama | RPL31 | PNKLytLVtyVPVttFKNLQtVNVDEN______________ |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | S54 | Sugiyama | TUBA1B | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q00839 | T530 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | KTTWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtG |
| Q01814 | T1241 | Sugiyama | ATP2B2 PMCA2 | TDtsKSATSSsPGsPIHSLEtsL__________________ |
| Q06830 | T166 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | DLPVGRsVDEtLRLVQAFQFtDKHGEVCPAGWKPGsDtIKP |
| Q06830 | T18 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | ___MSSGNAKIGHPAPNFKAtAVMPDGQFKDIsLsDyKGKY |
| Q13131 | T183 | SIGNOR|EPSD|PSP | PRKAA1 AMPK1 | NAKIADFGLsNMMsDGEFLRtsCGsPNyAAPEVISGRLYAG |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q14012 | T177 | GPS6|SIGNOR|iPTMNet | CAMK1 | KIMISDFGLSKMEDPGSVLstACGTPGYVAPEVLAQKPYSK |
| Q14444 | T303 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | YTEQSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEV |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q15084 | T166 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | YSSGKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFY |
| Q15181 | T245 | Sugiyama | PPA1 IOPPP PP | DHWKALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDA |
| Q15181 | T246 | Sugiyama | PPA1 IOPPP PP | HWKALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDAL |
| Q15293 | T211 | Sugiyama | RCN1 RCN | FTAFLHPEEFEHMKEIVVLEtLEDIDKNGDGFVDQDEyIAD |
| Q16566 | T200 | GPS6|SIGNOR|iPTMNet | CAMK4 CAMK CAMK-GR CAMKIV | PLKIADFGLsKIVEHQVLMKtVCGTPGYCAPEILRGCAYGP |
| Q4G0X9 | S553 | Sugiyama | CCDC40 KIAA1640 | EIEAYKKSIMKEEEKNEKLAsILNRTETEATLLQKLTTQCL |
| Q562R1 | T107 | Sugiyama | ACTBL2 | WYHTFYNELRVAPDEHPILLtEAPLNPKINREKMTQIMFEA |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FG1 | T34 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | KEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLGTITKSE |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | S54 | Sugiyama | TUBA3E | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | S54 | Sugiyama | TUBA1A TUBA3 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q86V81 | T148 | Sugiyama | ALYREF ALY BEF THOC4 | EFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQYNG |
| Q86W56 | Y832 | Sugiyama | PARG | DDWQRRCTEIVAIDALHFRRyLDQFVPEKMRRELNKAYCGF |
| Q8IU85 | T180 | GPS6 | CAMK1D CAMKID | KIMISDFGLSKMEGKGDVMstACGtPGYVAPEVLAQKPYSK |
| Q8IV50 | T210 | Sugiyama | LYSMD2 | STQAAKKLKEESRDEEsPyAtSLyHs_______________ |
| Q8NBJ5 | S616 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | EQQALSREAKNsDVLQsPLDsAARDEL______________ |
| Q8NBJ7 | S44 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | NGQATSMVQLQGGRFLMGtNsPDSRDGDGPVREATVKPFAI |
| Q8NBJ7 | T260 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | SPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMGNtPD |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q96EB6 | S27 | PSP | SIRT1 SIR2L1 | LALQPGGsPsAAGADREAAssPAGEPLRKRPRRDGPGLERs |
| Q96EB6 | S47 | PSP | SIRT1 SIR2L1 | sPAGEPLRKRPRRDGPGLERsPGEPGGAAPEREVPAAARGC |
| Q96RR4 | S100 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | EVPLDtsGSQARPHLSGRKLsLQERsQGGLAAGGsLDMNGR |
| Q96RR4 | S105 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | tsGSQARPHLSGRKLsLQERsQGGLAAGGsLDMNGRCICPs |
| Q96RR4 | S114 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | LSGRKLsLQERsQGGLAAGGsLDMNGRCICPsLPysPVssP |
| Q96RR4 | S125 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | sQGGLAAGGsLDMNGRCICPsLPysPVssPQssPRLPRRPT |
| Q96RR4 | S129 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | LAAGGsLDMNGRCICPsLPysPVssPQssPRLPRRPTVESH |
| Q96RR4 | S133 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | GsLDMNGRCICPsLPysPVssPQssPRLPRRPTVESHHVSI |
| Q96RR4 | S136 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | DMNGRCICPsLPysPVssPQssPRLPRRPTVESHHVSITGM |
| Q96RR4 | S137 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | MNGRCICPsLPysPVssPQssPRLPRRPTVESHHVSITGMQ |
| Q96RR4 | S26 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | SSQPSSNRAAPQDELGGRGSsSsEsQKPCEALRGLSSLSIH |
| Q96RR4 | S28 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | QPSSNRAAPQDELGGRGSsSsEsQKPCEALRGLSSLSIHLG |
| Q96RR4 | S30 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | SSNRAAPQDELGGRGSsSsEsQKPCEALRGLSSLSIHLGME |
| Q96RR4 | S503 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | tVILVKTMIRKRsFGNPFEGsRREERSLsAPGNLLTKKPTR |
| Q96RR4 | T216 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | LSKKKLIRQAGFPRRPPPRGtRPAPGGCIQPRGPIEQVYQE |
| Q96RR4 | T483 | SIGNOR | CAMKK2 CAMKKB KIAA0787 | LVEVTEEEVENSVKHIPSLAtVILVKTMIRKRsFGNPFEGs |
| Q96RR4 | T85 | EPSD|PSP | CAMKK2 CAMKKB KIAA0787 | DLGLARDRPLEADGQEVPLDtsGSQARPHLSGRKLsLQERs |
| Q96RR4 | Y128 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | GLAAGGsLDMNGRCICPsLPysPVssPQssPRLPRRPTVES |
| Q96RU3 | T537 | Sugiyama | FNBP1 FBP17 KIAA0554 | sPDGsYTEEQsQESEMKVLAtDFDDEFDDEEPLPAIGTCKA |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | S54 | Sugiyama | TUBA1C TUBA6 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BUJ2 | T113 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | SGPDGHYAMDNITRQNQFyDtQVIKQENESGyERRPLEMEQ |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BXS5 | T422 | Sugiyama | AP1M1 CLTNM | GYQALPWVRYITQNGDyQLRtQ___________________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9UNW1 | S468 | Sugiyama | MINPP1 MIPP UNQ900/PRO1917 | SQETVSFYEDLKNHYKDILQsCQTSEECELARANSTSDEL_ |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.448449e-07 | 6.352 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.018404e-06 | 5.695 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.098906e-06 | 5.678 | 1 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.519770e-06 | 5.345 | 1 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.974657e-06 | 5.001 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.247647e-05 | 4.904 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.155609e-05 | 4.666 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.636211e-05 | 4.579 | 1 | 1 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.704268e-05 | 4.568 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.366312e-05 | 4.473 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.309970e-05 | 4.366 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.025852e-05 | 4.299 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.950748e-05 | 4.305 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 5.409964e-05 | 4.267 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 6.693876e-05 | 4.174 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 8.150076e-05 | 4.089 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.609289e-05 | 4.065 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 8.799763e-05 | 4.056 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.395573e-04 | 3.855 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.463198e-04 | 3.835 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.542631e-04 | 3.812 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.905111e-04 | 3.720 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.865289e-04 | 3.729 | 1 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.153347e-04 | 3.501 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.112603e-04 | 3.507 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.426161e-04 | 3.465 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.559062e-04 | 3.449 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.938974e-04 | 3.405 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.080086e-04 | 3.389 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.339276e-04 | 3.363 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.307470e-04 | 3.366 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.437698e-04 | 3.353 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.697668e-04 | 3.328 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.965032e-04 | 3.304 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.266988e-04 | 3.278 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.522275e-04 | 3.186 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.102101e-04 | 3.215 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.300750e-04 | 3.201 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.435239e-04 | 3.191 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.705376e-04 | 3.174 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.693045e-04 | 3.174 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.538547e-04 | 3.123 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.571027e-04 | 3.121 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.858805e-04 | 3.105 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 9.036080e-04 | 3.044 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.356596e-04 | 3.029 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.009944e-03 | 2.996 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.027397e-03 | 2.988 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.027397e-03 | 2.988 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.096618e-03 | 2.960 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.096618e-03 | 2.960 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.052771e-03 | 2.978 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.145940e-03 | 2.941 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.302489e-03 | 2.885 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.412218e-03 | 2.850 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.412218e-03 | 2.850 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.686805e-03 | 2.773 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.944760e-03 | 2.711 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.946701e-03 | 2.711 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.949271e-03 | 2.710 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.949271e-03 | 2.710 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.122514e-03 | 2.673 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.154351e-03 | 2.667 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.163112e-03 | 2.665 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.232106e-03 | 2.651 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.515112e-03 | 2.599 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.568175e-03 | 2.590 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.568175e-03 | 2.590 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.795222e-03 | 2.554 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.824681e-03 | 2.549 | 1 | 1 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.333910e-03 | 2.477 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 3.652284e-03 | 2.437 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 3.652284e-03 | 2.437 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.670061e-03 | 2.435 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.842092e-03 | 2.415 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 3.866527e-03 | 2.413 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.674910e-03 | 2.330 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.674910e-03 | 2.330 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.460352e-03 | 2.351 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.693712e-03 | 2.328 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.598184e-03 | 2.337 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.527907e-03 | 2.344 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.674910e-03 | 2.330 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.587950e-03 | 2.253 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.848309e-03 | 2.233 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.848309e-03 | 2.233 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.848309e-03 | 2.233 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.848309e-03 | 2.233 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.848309e-03 | 2.233 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.848309e-03 | 2.233 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.848309e-03 | 2.233 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.848309e-03 | 2.233 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.404325e-03 | 2.267 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.587950e-03 | 2.253 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.174453e-03 | 2.286 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.692998e-03 | 2.245 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.349024e-03 | 2.272 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.907441e-03 | 2.229 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.313870e-03 | 2.200 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.492401e-03 | 2.188 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.650920e-03 | 2.177 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 7.202984e-03 | 2.142 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.352737e-03 | 2.134 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.038394e-03 | 2.153 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 7.246500e-03 | 2.140 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 7.398048e-03 | 2.131 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.519363e-03 | 2.124 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.546754e-03 | 2.122 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.287272e-03 | 2.082 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.379576e-03 | 2.077 | 1 | 0 |
| Muscle contraction | R-HSA-397014 | 8.379576e-03 | 2.077 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 7.728218e-03 | 2.112 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 8.936060e-03 | 2.049 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.026315e-03 | 2.044 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.304139e-03 | 2.031 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 9.854222e-03 | 2.006 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.854222e-03 | 2.006 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.023273e-02 | 1.990 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.023273e-02 | 1.990 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.049875e-02 | 1.979 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.092183e-02 | 1.962 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.092183e-02 | 1.962 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.092183e-02 | 1.962 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.092183e-02 | 1.962 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.049875e-02 | 1.979 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.197083e-02 | 1.922 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.197083e-02 | 1.922 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.228729e-02 | 1.911 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.378730e-02 | 1.861 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.378730e-02 | 1.861 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.378730e-02 | 1.861 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.450542e-02 | 1.838 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.378730e-02 | 1.861 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.343048e-02 | 1.872 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.318935e-02 | 1.880 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.428378e-02 | 1.845 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.463882e-02 | 1.834 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.463882e-02 | 1.834 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.463882e-02 | 1.834 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.509870e-02 | 1.821 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.586475e-02 | 1.800 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.633451e-02 | 1.787 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.658350e-02 | 1.780 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.698328e-02 | 1.770 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.698328e-02 | 1.770 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.093133e-02 | 1.679 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.155731e-02 | 1.666 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.935459e-02 | 1.713 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.082988e-02 | 1.681 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.983641e-02 | 1.703 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.018891e-02 | 1.695 | 1 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.211553e-02 | 1.655 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.272155e-02 | 1.644 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.272155e-02 | 1.644 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.310120e-02 | 1.636 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.350689e-02 | 1.629 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.395012e-02 | 1.621 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.395012e-02 | 1.621 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.397611e-02 | 1.620 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.397611e-02 | 1.620 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.470536e-02 | 1.607 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.470536e-02 | 1.607 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.470536e-02 | 1.607 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.470536e-02 | 1.607 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.470536e-02 | 1.607 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.470536e-02 | 1.607 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.477177e-02 | 1.606 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.928899e-02 | 1.533 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.726858e-02 | 1.564 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.943532e-02 | 1.531 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.943532e-02 | 1.531 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.849361e-02 | 1.545 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.013396e-02 | 1.521 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.053676e-02 | 1.515 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.053676e-02 | 1.515 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.280672e-02 | 1.484 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.347340e-02 | 1.475 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.460806e-02 | 1.461 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.460806e-02 | 1.461 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.476736e-02 | 1.459 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.630921e-02 | 1.440 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.654553e-02 | 1.437 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 4.307516e-02 | 1.366 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 4.307516e-02 | 1.366 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 4.307516e-02 | 1.366 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 3.874275e-02 | 1.412 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.021801e-02 | 1.396 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.874275e-02 | 1.412 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.874275e-02 | 1.412 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.947968e-02 | 1.404 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.264631e-02 | 1.370 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.899426e-02 | 1.409 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.330821e-02 | 1.363 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.874275e-02 | 1.412 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.066927e-02 | 1.391 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.324255e-02 | 1.364 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.438968e-02 | 1.353 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.448967e-02 | 1.352 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.504621e-02 | 1.346 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.504621e-02 | 1.346 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.589919e-02 | 1.338 | 1 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.693288e-02 | 1.329 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.790056e-02 | 1.320 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.900559e-02 | 1.310 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.900559e-02 | 1.310 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.900559e-02 | 1.310 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.918297e-02 | 1.308 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.918297e-02 | 1.308 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.455716e-02 | 1.263 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 5.927567e-02 | 1.227 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 5.927567e-02 | 1.227 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.958572e-02 | 1.225 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.455716e-02 | 1.263 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.183009e-02 | 1.285 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.958572e-02 | 1.225 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.958572e-02 | 1.225 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 5.334944e-02 | 1.273 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.678909e-02 | 1.246 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.271715e-02 | 1.278 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.032561e-02 | 1.298 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.271715e-02 | 1.278 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.266651e-02 | 1.278 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.885618e-02 | 1.230 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.271715e-02 | 1.278 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.364978e-02 | 1.270 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.965879e-02 | 1.224 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.032537e-02 | 1.220 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.032537e-02 | 1.220 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.050736e-02 | 1.218 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 6.050736e-02 | 1.218 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.110361e-02 | 1.214 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.129477e-02 | 1.213 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.220276e-02 | 1.206 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.247877e-02 | 1.204 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.302859e-02 | 1.200 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.318049e-02 | 1.199 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.318049e-02 | 1.199 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.629458e-02 | 1.179 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.685079e-02 | 1.175 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 8.429736e-02 | 1.074 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 8.429736e-02 | 1.074 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 8.429736e-02 | 1.074 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 8.429736e-02 | 1.074 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 8.429736e-02 | 1.074 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 8.429736e-02 | 1.074 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 7.262062e-02 | 1.139 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 7.262062e-02 | 1.139 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.262062e-02 | 1.139 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.068821e-02 | 1.151 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.655047e-02 | 1.116 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.076184e-02 | 1.150 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 8.264868e-02 | 1.083 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 8.251482e-02 | 1.083 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 8.251482e-02 | 1.083 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 7.262062e-02 | 1.139 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.024352e-02 | 1.153 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.853950e-02 | 1.105 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.452332e-02 | 1.128 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 8.288546e-02 | 1.082 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.767896e-02 | 1.170 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.088656e-02 | 1.149 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.635851e-02 | 1.117 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.312789e-02 | 1.080 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.235063e-02 | 1.141 | 1 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.102318e-02 | 1.149 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.880260e-02 | 1.162 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.251482e-02 | 1.083 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 8.251482e-02 | 1.083 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.655047e-02 | 1.116 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.264868e-02 | 1.083 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.733087e-02 | 1.112 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.430820e-02 | 1.074 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.251482e-02 | 1.083 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.220828e-02 | 1.085 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.163828e-02 | 1.088 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.503094e-02 | 1.070 | 1 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.505986e-02 | 1.070 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 8.543398e-02 | 1.068 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 8.543398e-02 | 1.068 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 8.543398e-02 | 1.068 | 1 | 1 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 8.740210e-02 | 1.058 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.843131e-02 | 1.053 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.088369e-02 | 1.042 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.115091e-02 | 1.040 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.389603e-02 | 1.027 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 9.442268e-02 | 1.025 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 9.553325e-02 | 1.020 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 9.553325e-02 | 1.020 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 9.553325e-02 | 1.020 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 9.553325e-02 | 1.020 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.553325e-02 | 1.020 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 9.670498e-02 | 1.015 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.670498e-02 | 1.015 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.670498e-02 | 1.015 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.744877e-02 | 1.011 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.825293e-02 | 1.008 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.834681e-02 | 1.007 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 9.886485e-02 | 1.005 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 9.886485e-02 | 1.005 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 9.886485e-02 | 1.005 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 9.886485e-02 | 1.005 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 9.886485e-02 | 1.005 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 9.958921e-02 | 1.002 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.006525e-01 | 0.997 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.009872e-01 | 0.996 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.023087e-01 | 0.990 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.039274e-01 | 0.983 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 1.237462e-01 | 0.907 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.237462e-01 | 0.907 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 1.237462e-01 | 0.907 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 1.237462e-01 | 0.907 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 1.237462e-01 | 0.907 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.128364e-01 | 0.948 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.128364e-01 | 0.948 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.128364e-01 | 0.948 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.272774e-01 | 0.895 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 1.275575e-01 | 0.894 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.092982e-01 | 0.961 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.314857e-01 | 0.881 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.314857e-01 | 0.881 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.116713e-01 | 0.952 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.086373e-01 | 0.964 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.275575e-01 | 0.894 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.119324e-01 | 0.951 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.393265e-01 | 0.856 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.316031e-01 | 0.881 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.237462e-01 | 0.907 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.272774e-01 | 0.895 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.275575e-01 | 0.894 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.164954e-01 | 0.934 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.206599e-01 | 0.918 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.238936e-01 | 0.907 | 1 | 0 |
| Gastrulation | R-HSA-9758941 | 1.243181e-01 | 0.905 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.238936e-01 | 0.907 | 1 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.218896e-01 | 0.914 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.086147e-01 | 0.964 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.237462e-01 | 0.907 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.272774e-01 | 0.895 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.393265e-01 | 0.856 | 1 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.300648e-01 | 0.886 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.272774e-01 | 0.895 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.384390e-01 | 0.859 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 1.392644e-01 | 0.856 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.272774e-01 | 0.895 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.238936e-01 | 0.907 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.421215e-01 | 0.847 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.421215e-01 | 0.847 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.426483e-01 | 0.846 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.428033e-01 | 0.845 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.614978e-01 | 0.792 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 1.614978e-01 | 0.792 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 1.614978e-01 | 0.792 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 1.976252e-01 | 0.704 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 1.976252e-01 | 0.704 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.321982e-01 | 0.634 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.321982e-01 | 0.634 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.321982e-01 | 0.634 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.321982e-01 | 0.634 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.321982e-01 | 0.634 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 2.321982e-01 | 0.634 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.321982e-01 | 0.634 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.652834e-01 | 0.576 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.652834e-01 | 0.576 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.573073e-01 | 0.803 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.573073e-01 | 0.803 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.573073e-01 | 0.803 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 2.969449e-01 | 0.527 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 2.969449e-01 | 0.527 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.969449e-01 | 0.527 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.969449e-01 | 0.527 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.969449e-01 | 0.527 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.727781e-01 | 0.763 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.272438e-01 | 0.485 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.272438e-01 | 0.485 | 0 | 0 |
| Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) | R-HSA-3656244 | 3.272438e-01 | 0.485 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.272438e-01 | 0.485 | 0 | 0 |
| Defective CHST6 causes MCDC1 | R-HSA-3656225 | 3.272438e-01 | 0.485 | 0 | 0 |
| Defective ST3GAL3 causes MCT12 and EIEE15 | R-HSA-3656243 | 3.272438e-01 | 0.485 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.272438e-01 | 0.485 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.272438e-01 | 0.485 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 2.043677e-01 | 0.690 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.475732e-01 | 0.831 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.562388e-01 | 0.448 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.562388e-01 | 0.448 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.562388e-01 | 0.448 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.562388e-01 | 0.448 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 3.562388e-01 | 0.448 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.562388e-01 | 0.448 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 2.365160e-01 | 0.626 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.365160e-01 | 0.626 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.793022e-01 | 0.746 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.839858e-01 | 0.416 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.839858e-01 | 0.416 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.472222e-01 | 0.832 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.689047e-01 | 0.570 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.013903e-01 | 0.696 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.553515e-01 | 0.809 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.126646e-01 | 0.672 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.851036e-01 | 0.545 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.105384e-01 | 0.387 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.105384e-01 | 0.387 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.105384e-01 | 0.387 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.240707e-01 | 0.650 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.240707e-01 | 0.650 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.472153e-01 | 0.607 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.173632e-01 | 0.498 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 3.173632e-01 | 0.498 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.359481e-01 | 0.361 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.359481e-01 | 0.361 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.688179e-01 | 0.773 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 3.333727e-01 | 0.477 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.825391e-01 | 0.549 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.492716e-01 | 0.457 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.060077e-01 | 0.686 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.060077e-01 | 0.686 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.819750e-01 | 0.740 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.944189e-01 | 0.531 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.650398e-01 | 0.438 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.826420e-01 | 0.549 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.537341e-01 | 0.596 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.021472e-01 | 0.520 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.119574e-01 | 0.506 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.869311e-01 | 0.542 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.264667e-01 | 0.370 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.264667e-01 | 0.370 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.264667e-01 | 0.370 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.038239e-01 | 0.517 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.514154e-01 | 0.454 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.514154e-01 | 0.454 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.514154e-01 | 0.454 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.514154e-01 | 0.454 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.514154e-01 | 0.454 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.799193e-01 | 0.553 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.161931e-01 | 0.665 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.069248e-01 | 0.390 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.851916e-01 | 0.545 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.255952e-01 | 0.647 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.707028e-01 | 0.568 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.443034e-01 | 0.612 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.547461e-01 | 0.810 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.129805e-01 | 0.384 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.618940e-01 | 0.441 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.760355e-01 | 0.754 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.063291e-01 | 0.514 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.727781e-01 | 0.763 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.720927e-01 | 0.764 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.375093e-01 | 0.624 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.182570e-01 | 0.497 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.573073e-01 | 0.803 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.689047e-01 | 0.570 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 2.619474e-01 | 0.582 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.359481e-01 | 0.361 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.944189e-01 | 0.531 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.264667e-01 | 0.370 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.819347e-01 | 0.550 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.492458e-01 | 0.457 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.702213e-01 | 0.568 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.702213e-01 | 0.568 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.579396e-01 | 0.802 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.492458e-01 | 0.457 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.573073e-01 | 0.803 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.969449e-01 | 0.527 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.727781e-01 | 0.763 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.043677e-01 | 0.690 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.839858e-01 | 0.416 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.689047e-01 | 0.570 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.105384e-01 | 0.387 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.633787e-01 | 0.440 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.573073e-01 | 0.803 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.573073e-01 | 0.803 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.598606e-01 | 0.585 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.301908e-01 | 0.481 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.720927e-01 | 0.764 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.421188e-01 | 0.466 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.846519e-01 | 0.415 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.652834e-01 | 0.576 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.562388e-01 | 0.448 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.562388e-01 | 0.448 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.365160e-01 | 0.626 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.472153e-01 | 0.607 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.359481e-01 | 0.361 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.224075e-01 | 0.653 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.799193e-01 | 0.553 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.294217e-01 | 0.482 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.785509e-01 | 0.555 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.908108e-01 | 0.719 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 2.126646e-01 | 0.672 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.321982e-01 | 0.634 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.321982e-01 | 0.634 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.969449e-01 | 0.527 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.365160e-01 | 0.626 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.105384e-01 | 0.387 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.659135e-01 | 0.437 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.810899e-01 | 0.419 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.069224e-01 | 0.513 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.129805e-01 | 0.384 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.953571e-01 | 0.530 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 2.072802e-01 | 0.683 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.553515e-01 | 0.809 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.553515e-01 | 0.809 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.806589e-01 | 0.419 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.826420e-01 | 0.549 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.105384e-01 | 0.387 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.707028e-01 | 0.568 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.673129e-01 | 0.435 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.909250e-01 | 0.536 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.333727e-01 | 0.477 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.301908e-01 | 0.481 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.351750e-01 | 0.475 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.357875e-01 | 0.627 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.833680e-01 | 0.737 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.357875e-01 | 0.627 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.537715e-01 | 0.596 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.292987e-01 | 0.482 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.855446e-01 | 0.732 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.321982e-01 | 0.634 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.652834e-01 | 0.576 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.652834e-01 | 0.576 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.969449e-01 | 0.527 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 2.969449e-01 | 0.527 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 2.969449e-01 | 0.527 | 0 | 0 |
| Threonine catabolism | R-HSA-8849175 | 2.969449e-01 | 0.527 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.727781e-01 | 0.763 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.272438e-01 | 0.485 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.562388e-01 | 0.448 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.562388e-01 | 0.448 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 3.839858e-01 | 0.416 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.839858e-01 | 0.416 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 1.902640e-01 | 0.721 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.902640e-01 | 0.721 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 1.553515e-01 | 0.809 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 1.553515e-01 | 0.809 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.359481e-01 | 0.361 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 4.359481e-01 | 0.361 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.359481e-01 | 0.361 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.333727e-01 | 0.477 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.707028e-01 | 0.568 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.063291e-01 | 0.514 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.742033e-01 | 0.759 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 3.961127e-01 | 0.402 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.264667e-01 | 0.370 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.537715e-01 | 0.596 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.613002e-01 | 0.442 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.129805e-01 | 0.384 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.869311e-01 | 0.542 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 3.839858e-01 | 0.416 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.272960e-01 | 0.643 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.606138e-01 | 0.443 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.421188e-01 | 0.466 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.485340e-01 | 0.605 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.839858e-01 | 0.416 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.538736e-01 | 0.451 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.810492e-01 | 0.419 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.457249e-01 | 0.836 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.011829e-01 | 0.696 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.671799e-01 | 0.777 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.310650e-01 | 0.365 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.321982e-01 | 0.634 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.884811e-01 | 0.725 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.562388e-01 | 0.448 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 4.105384e-01 | 0.387 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 4.359481e-01 | 0.361 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.589235e-01 | 0.587 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 3.492716e-01 | 0.457 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.182570e-01 | 0.497 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.723160e-01 | 0.429 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.207994e-01 | 0.376 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.338370e-01 | 0.363 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.908108e-01 | 0.719 | 1 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.851036e-01 | 0.545 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 2.163844e-01 | 0.665 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.492716e-01 | 0.457 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.963218e-01 | 0.707 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.851036e-01 | 0.545 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.209260e-01 | 0.656 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.476080e-01 | 0.606 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.652834e-01 | 0.576 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.969449e-01 | 0.527 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.884811e-01 | 0.725 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.043677e-01 | 0.690 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 2.365160e-01 | 0.626 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 3.839858e-01 | 0.416 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.839858e-01 | 0.416 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.851036e-01 | 0.545 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.105384e-01 | 0.387 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.487281e-01 | 0.458 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.487281e-01 | 0.458 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.487281e-01 | 0.458 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.072802e-01 | 0.683 | 1 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.909012e-01 | 0.408 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.106813e-01 | 0.386 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.355885e-01 | 0.474 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.552033e-01 | 0.809 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.727781e-01 | 0.763 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.806589e-01 | 0.419 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.375093e-01 | 0.624 | 1 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.359481e-01 | 0.361 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.707028e-01 | 0.568 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.825391e-01 | 0.549 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 4.264667e-01 | 0.370 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.895589e-01 | 0.409 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.229561e-01 | 0.491 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.240536e-01 | 0.650 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.144337e-01 | 0.669 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.689047e-01 | 0.570 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.129805e-01 | 0.384 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.129805e-01 | 0.384 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.114816e-01 | 0.507 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 4.326156e-01 | 0.364 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.343025e-01 | 0.362 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.953571e-01 | 0.530 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.727781e-01 | 0.763 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.203931e-01 | 0.657 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.562388e-01 | 0.448 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.579396e-01 | 0.802 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.839858e-01 | 0.416 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.839858e-01 | 0.416 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.839858e-01 | 0.416 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.105384e-01 | 0.387 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 4.359481e-01 | 0.361 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.944189e-01 | 0.531 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.421188e-01 | 0.466 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.421188e-01 | 0.466 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.540298e-01 | 0.451 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.810492e-01 | 0.419 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.783834e-01 | 0.555 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.151990e-01 | 0.667 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.264667e-01 | 0.370 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.982907e-01 | 0.703 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.894241e-01 | 0.723 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.743968e-01 | 0.758 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 4.155094e-01 | 0.381 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.105384e-01 | 0.387 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.552174e-01 | 0.450 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.163844e-01 | 0.665 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.707028e-01 | 0.568 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.063291e-01 | 0.514 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.514154e-01 | 0.454 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.652834e-01 | 0.576 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.969449e-01 | 0.527 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.272438e-01 | 0.485 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.043677e-01 | 0.690 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.105384e-01 | 0.387 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 3.012653e-01 | 0.521 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.492716e-01 | 0.457 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.650398e-01 | 0.438 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.182570e-01 | 0.497 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.245863e-01 | 0.372 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.010185e-01 | 0.521 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.283420e-01 | 0.484 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 3.272438e-01 | 0.485 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.961127e-01 | 0.402 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.012653e-01 | 0.521 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.619474e-01 | 0.582 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 3.806589e-01 | 0.419 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.909012e-01 | 0.408 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.641905e-01 | 0.439 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.461482e-01 | 0.835 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.119574e-01 | 0.506 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.073007e-01 | 0.512 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.969449e-01 | 0.527 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 2.969449e-01 | 0.527 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.727781e-01 | 0.763 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.203931e-01 | 0.657 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.333727e-01 | 0.477 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.301908e-01 | 0.481 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.769336e-01 | 0.558 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.995748e-01 | 0.523 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.785509e-01 | 0.555 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.012653e-01 | 0.521 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.492716e-01 | 0.457 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.245863e-01 | 0.372 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.245863e-01 | 0.372 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.652834e-01 | 0.576 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.359481e-01 | 0.361 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.333727e-01 | 0.477 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.113863e-01 | 0.386 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.536222e-01 | 0.814 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 3.650398e-01 | 0.438 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.895589e-01 | 0.409 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.652834e-01 | 0.576 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.793022e-01 | 0.746 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.689047e-01 | 0.570 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.333727e-01 | 0.477 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.113863e-01 | 0.386 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.311139e-01 | 0.636 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.564535e-01 | 0.448 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.173632e-01 | 0.498 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.526982e-01 | 0.597 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.851036e-01 | 0.545 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.727781e-01 | 0.763 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.105384e-01 | 0.387 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.113863e-01 | 0.386 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.689047e-01 | 0.570 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.806589e-01 | 0.419 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.806589e-01 | 0.419 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.013903e-01 | 0.696 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.147049e-01 | 0.668 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.119574e-01 | 0.506 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.760355e-01 | 0.754 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.359481e-01 | 0.361 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.507877e-01 | 0.822 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 3.650398e-01 | 0.438 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.361116e-01 | 0.360 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.411299e-01 | 0.355 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.413420e-01 | 0.355 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.413420e-01 | 0.355 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.413420e-01 | 0.355 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.413420e-01 | 0.355 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.413420e-01 | 0.355 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.413420e-01 | 0.355 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.415236e-01 | 0.355 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.458051e-01 | 0.351 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.491896e-01 | 0.348 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.491896e-01 | 0.348 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.493482e-01 | 0.347 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.493482e-01 | 0.347 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.496137e-01 | 0.347 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.496137e-01 | 0.347 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.560020e-01 | 0.341 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.560020e-01 | 0.341 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.560020e-01 | 0.341 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.560020e-01 | 0.341 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.580637e-01 | 0.339 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.587820e-01 | 0.338 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.588928e-01 | 0.338 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.588928e-01 | 0.338 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.598527e-01 | 0.337 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.602639e-01 | 0.337 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.602639e-01 | 0.337 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.602639e-01 | 0.337 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.602639e-01 | 0.337 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.602639e-01 | 0.337 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.605140e-01 | 0.337 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.644503e-01 | 0.333 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.644503e-01 | 0.333 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.664768e-01 | 0.331 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.684567e-01 | 0.329 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.701357e-01 | 0.328 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.704376e-01 | 0.327 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.704376e-01 | 0.327 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.704376e-01 | 0.327 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.720399e-01 | 0.326 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.748497e-01 | 0.323 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.779204e-01 | 0.321 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.795993e-01 | 0.319 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.831795e-01 | 0.316 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.833626e-01 | 0.316 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.835329e-01 | 0.316 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.835329e-01 | 0.316 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.835329e-01 | 0.316 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.835329e-01 | 0.316 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.835329e-01 | 0.316 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.835329e-01 | 0.316 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.835329e-01 | 0.316 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.835329e-01 | 0.316 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.835329e-01 | 0.316 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.835329e-01 | 0.316 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.835329e-01 | 0.316 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.846410e-01 | 0.315 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.846410e-01 | 0.315 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.846410e-01 | 0.315 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.846410e-01 | 0.315 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.873185e-01 | 0.312 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.873185e-01 | 0.312 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.914632e-01 | 0.309 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.922965e-01 | 0.308 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.922965e-01 | 0.308 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.922965e-01 | 0.308 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.922965e-01 | 0.308 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.946181e-01 | 0.306 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.966471e-01 | 0.304 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.986053e-01 | 0.302 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.986053e-01 | 0.302 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.996982e-01 | 0.301 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.996982e-01 | 0.301 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.020527e-01 | 0.299 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.032039e-01 | 0.298 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.032039e-01 | 0.298 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.057285e-01 | 0.296 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.058001e-01 | 0.296 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.058001e-01 | 0.296 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.058001e-01 | 0.296 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.058001e-01 | 0.296 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 5.058001e-01 | 0.296 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.058001e-01 | 0.296 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 5.058001e-01 | 0.296 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.058001e-01 | 0.296 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 5.058001e-01 | 0.296 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.058001e-01 | 0.296 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.058001e-01 | 0.296 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.058001e-01 | 0.296 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.058001e-01 | 0.296 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.059027e-01 | 0.296 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.059027e-01 | 0.296 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.070296e-01 | 0.295 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.072227e-01 | 0.295 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.108700e-01 | 0.292 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.123234e-01 | 0.290 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.123248e-01 | 0.290 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.123248e-01 | 0.290 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.123248e-01 | 0.290 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.139896e-01 | 0.289 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.168643e-01 | 0.287 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.241813e-01 | 0.281 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.246493e-01 | 0.280 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 5.257946e-01 | 0.279 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.259455e-01 | 0.279 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 5.271086e-01 | 0.278 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.271086e-01 | 0.278 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.271086e-01 | 0.278 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.271086e-01 | 0.278 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.271086e-01 | 0.278 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 5.271086e-01 | 0.278 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.271086e-01 | 0.278 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 5.271086e-01 | 0.278 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.271086e-01 | 0.278 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.271086e-01 | 0.278 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.351790e-01 | 0.272 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.351790e-01 | 0.272 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.390107e-01 | 0.268 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.390107e-01 | 0.268 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.455752e-01 | 0.263 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.455752e-01 | 0.263 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.455752e-01 | 0.263 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 5.455752e-01 | 0.263 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.474995e-01 | 0.262 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.474995e-01 | 0.262 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.474995e-01 | 0.262 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.474995e-01 | 0.262 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.474995e-01 | 0.262 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.474995e-01 | 0.262 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.474995e-01 | 0.262 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.509721e-01 | 0.259 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.512383e-01 | 0.259 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 5.519700e-01 | 0.258 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 5.519700e-01 | 0.258 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.519700e-01 | 0.258 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.524635e-01 | 0.258 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.558345e-01 | 0.255 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.558345e-01 | 0.255 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.560669e-01 | 0.255 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.576931e-01 | 0.254 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.597243e-01 | 0.252 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.646701e-01 | 0.248 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.646701e-01 | 0.248 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.659541e-01 | 0.247 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.659541e-01 | 0.247 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 5.659541e-01 | 0.247 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.659550e-01 | 0.247 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.670124e-01 | 0.246 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.670124e-01 | 0.246 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.670124e-01 | 0.246 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.670124e-01 | 0.246 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 5.670124e-01 | 0.246 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.670124e-01 | 0.246 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.670124e-01 | 0.246 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.670124e-01 | 0.246 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.670124e-01 | 0.246 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 5.670124e-01 | 0.246 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.670124e-01 | 0.246 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.670124e-01 | 0.246 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.670124e-01 | 0.246 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.670124e-01 | 0.246 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.670124e-01 | 0.246 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.671853e-01 | 0.246 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.751149e-01 | 0.240 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.788275e-01 | 0.237 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.854139e-01 | 0.233 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.854139e-01 | 0.233 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.856849e-01 | 0.232 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.856849e-01 | 0.232 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.856849e-01 | 0.232 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.856849e-01 | 0.232 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.856849e-01 | 0.232 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.856849e-01 | 0.232 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.856849e-01 | 0.232 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.856849e-01 | 0.232 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.856849e-01 | 0.232 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.856849e-01 | 0.232 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.856849e-01 | 0.232 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.856849e-01 | 0.232 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.857636e-01 | 0.232 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.857636e-01 | 0.232 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 5.938433e-01 | 0.226 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.954491e-01 | 0.225 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.954491e-01 | 0.225 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.954491e-01 | 0.225 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.954491e-01 | 0.225 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.954491e-01 | 0.225 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.012006e-01 | 0.221 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 6.012006e-01 | 0.221 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.012006e-01 | 0.221 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.016836e-01 | 0.221 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.035533e-01 | 0.219 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.035533e-01 | 0.219 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.035533e-01 | 0.219 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.035533e-01 | 0.219 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 6.035533e-01 | 0.219 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.035533e-01 | 0.219 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.035533e-01 | 0.219 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.035533e-01 | 0.219 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.035533e-01 | 0.219 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 6.035533e-01 | 0.219 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.049861e-01 | 0.218 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.085577e-01 | 0.216 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.085577e-01 | 0.216 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.095093e-01 | 0.215 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.095093e-01 | 0.215 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.100093e-01 | 0.215 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.128524e-01 | 0.213 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.128524e-01 | 0.213 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.128524e-01 | 0.213 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.128524e-01 | 0.213 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.128524e-01 | 0.213 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.128524e-01 | 0.213 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.143729e-01 | 0.212 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.152635e-01 | 0.211 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.157986e-01 | 0.211 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.182728e-01 | 0.209 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.182728e-01 | 0.209 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.186597e-01 | 0.209 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.206521e-01 | 0.207 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.206521e-01 | 0.207 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.206521e-01 | 0.207 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.206521e-01 | 0.207 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.206521e-01 | 0.207 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.206521e-01 | 0.207 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.206521e-01 | 0.207 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 6.206521e-01 | 0.207 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.206521e-01 | 0.207 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.206521e-01 | 0.207 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.206521e-01 | 0.207 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.206521e-01 | 0.207 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.214039e-01 | 0.207 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.236083e-01 | 0.205 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.236083e-01 | 0.205 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 6.242420e-01 | 0.205 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 6.242420e-01 | 0.205 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.353704e-01 | 0.197 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 6.353704e-01 | 0.197 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.370145e-01 | 0.196 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.370145e-01 | 0.196 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.370145e-01 | 0.196 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.370145e-01 | 0.196 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.370145e-01 | 0.196 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.370145e-01 | 0.196 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.416210e-01 | 0.193 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.426697e-01 | 0.192 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.439601e-01 | 0.191 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 6.462390e-01 | 0.190 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 6.462390e-01 | 0.190 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 6.488861e-01 | 0.188 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.503969e-01 | 0.187 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.526720e-01 | 0.185 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.526720e-01 | 0.185 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.526720e-01 | 0.185 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 6.526720e-01 | 0.185 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.526720e-01 | 0.185 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.526720e-01 | 0.185 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 6.526720e-01 | 0.185 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.526720e-01 | 0.185 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.526720e-01 | 0.185 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 6.526720e-01 | 0.185 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.526720e-01 | 0.185 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.526720e-01 | 0.185 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 6.526720e-01 | 0.185 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.526720e-01 | 0.185 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.526720e-01 | 0.185 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.569790e-01 | 0.182 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.672037e-01 | 0.176 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.672037e-01 | 0.176 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.676551e-01 | 0.175 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.676551e-01 | 0.175 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.676551e-01 | 0.175 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.676551e-01 | 0.175 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.676551e-01 | 0.175 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.676551e-01 | 0.175 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 6.676551e-01 | 0.175 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.676551e-01 | 0.175 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.676551e-01 | 0.175 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.676551e-01 | 0.175 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 6.676551e-01 | 0.175 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.676551e-01 | 0.175 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.715422e-01 | 0.173 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.757984e-01 | 0.170 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.757984e-01 | 0.170 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.773042e-01 | 0.169 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.773042e-01 | 0.169 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.773042e-01 | 0.169 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.775024e-01 | 0.169 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.788964e-01 | 0.168 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.819927e-01 | 0.166 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.819927e-01 | 0.166 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.819927e-01 | 0.166 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 6.819927e-01 | 0.166 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.819927e-01 | 0.166 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.819927e-01 | 0.166 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.819927e-01 | 0.166 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 6.819927e-01 | 0.166 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 6.819927e-01 | 0.166 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.819927e-01 | 0.166 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 6.839567e-01 | 0.165 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.859814e-01 | 0.164 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.871535e-01 | 0.163 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.871535e-01 | 0.163 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.919610e-01 | 0.160 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.949610e-01 | 0.158 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.957125e-01 | 0.158 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.957125e-01 | 0.158 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.967546e-01 | 0.157 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.065709e-01 | 0.151 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.075095e-01 | 0.150 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.088413e-01 | 0.149 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.088413e-01 | 0.149 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.088413e-01 | 0.149 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 7.088413e-01 | 0.149 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.088413e-01 | 0.149 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 7.088413e-01 | 0.149 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.132122e-01 | 0.147 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.152244e-01 | 0.146 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.214044e-01 | 0.142 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.214044e-01 | 0.142 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.214044e-01 | 0.142 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 7.214044e-01 | 0.142 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 7.214044e-01 | 0.142 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.214044e-01 | 0.142 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.214044e-01 | 0.142 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.214044e-01 | 0.142 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.214044e-01 | 0.142 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.240998e-01 | 0.140 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.261631e-01 | 0.139 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.295555e-01 | 0.137 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.296931e-01 | 0.137 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.324732e-01 | 0.135 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.327404e-01 | 0.135 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.327404e-01 | 0.135 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.334261e-01 | 0.135 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 7.334261e-01 | 0.135 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.334261e-01 | 0.135 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.334261e-01 | 0.135 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.334261e-01 | 0.135 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.334261e-01 | 0.135 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.334261e-01 | 0.135 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.367877e-01 | 0.133 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.367877e-01 | 0.133 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.386736e-01 | 0.132 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.411498e-01 | 0.130 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 7.411498e-01 | 0.130 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.411498e-01 | 0.130 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.437342e-01 | 0.129 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.447647e-01 | 0.128 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.449298e-01 | 0.128 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.449298e-01 | 0.128 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.449298e-01 | 0.128 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.449298e-01 | 0.128 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.449298e-01 | 0.128 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.449298e-01 | 0.128 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.449298e-01 | 0.128 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.449298e-01 | 0.128 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.449298e-01 | 0.128 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.493319e-01 | 0.125 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.493319e-01 | 0.125 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.538165e-01 | 0.123 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.547006e-01 | 0.122 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.559377e-01 | 0.122 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.559377e-01 | 0.122 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.559377e-01 | 0.122 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.559377e-01 | 0.122 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.559377e-01 | 0.122 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.559377e-01 | 0.122 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.559377e-01 | 0.122 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.559377e-01 | 0.122 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.572906e-01 | 0.121 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.583614e-01 | 0.120 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.583614e-01 | 0.120 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.631785e-01 | 0.117 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.636987e-01 | 0.117 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.664712e-01 | 0.116 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.664712e-01 | 0.116 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.664712e-01 | 0.116 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.664712e-01 | 0.116 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 7.664712e-01 | 0.116 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.664712e-01 | 0.116 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.680485e-01 | 0.115 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.680485e-01 | 0.115 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.691902e-01 | 0.114 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.700667e-01 | 0.113 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 7.718685e-01 | 0.112 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 7.718685e-01 | 0.112 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.725543e-01 | 0.112 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.725543e-01 | 0.112 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.725543e-01 | 0.112 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.744915e-01 | 0.111 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.765507e-01 | 0.110 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.765507e-01 | 0.110 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.765507e-01 | 0.110 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.789765e-01 | 0.108 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.823821e-01 | 0.107 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.861957e-01 | 0.104 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.861957e-01 | 0.104 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.861957e-01 | 0.104 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 7.861957e-01 | 0.104 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.861957e-01 | 0.104 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.861957e-01 | 0.104 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.861957e-01 | 0.104 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.861957e-01 | 0.104 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.861957e-01 | 0.104 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.862021e-01 | 0.104 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.862021e-01 | 0.104 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.938773e-01 | 0.100 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.938773e-01 | 0.100 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.949215e-01 | 0.100 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.954250e-01 | 0.099 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.954250e-01 | 0.099 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.954250e-01 | 0.099 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.954250e-01 | 0.099 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.954250e-01 | 0.099 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.954250e-01 | 0.099 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.954250e-01 | 0.099 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.954250e-01 | 0.099 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.042564e-01 | 0.095 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.042564e-01 | 0.095 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.042564e-01 | 0.095 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.042564e-01 | 0.095 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.042564e-01 | 0.095 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 8.070935e-01 | 0.093 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.070935e-01 | 0.093 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.095903e-01 | 0.092 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.107986e-01 | 0.091 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.127071e-01 | 0.090 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.127071e-01 | 0.090 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.127071e-01 | 0.090 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.134146e-01 | 0.090 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 8.134146e-01 | 0.090 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.199573e-01 | 0.086 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.202306e-01 | 0.086 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.202306e-01 | 0.086 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.202306e-01 | 0.086 | 0 | 0 |
| Keratan sulfate biosynthesis | R-HSA-2022854 | 8.207934e-01 | 0.086 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.207934e-01 | 0.086 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.207934e-01 | 0.086 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 8.207934e-01 | 0.086 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.207934e-01 | 0.086 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.207934e-01 | 0.086 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.207934e-01 | 0.086 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.255041e-01 | 0.083 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.273255e-01 | 0.082 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.285311e-01 | 0.082 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.285311e-01 | 0.082 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.285311e-01 | 0.082 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.285311e-01 | 0.082 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.285311e-01 | 0.082 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.285311e-01 | 0.082 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.285311e-01 | 0.082 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.285311e-01 | 0.082 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.285311e-01 | 0.082 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.359352e-01 | 0.078 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.359352e-01 | 0.078 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.359352e-01 | 0.078 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.359352e-01 | 0.078 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.359352e-01 | 0.078 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.359352e-01 | 0.078 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.359352e-01 | 0.078 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.359352e-01 | 0.078 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.359352e-01 | 0.078 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.359352e-01 | 0.078 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.359352e-01 | 0.078 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.359352e-01 | 0.078 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.360152e-01 | 0.078 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.423198e-01 | 0.075 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.430199e-01 | 0.074 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.430199e-01 | 0.074 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.430199e-01 | 0.074 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 8.430199e-01 | 0.074 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.475901e-01 | 0.072 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.497129e-01 | 0.071 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.497992e-01 | 0.071 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.497992e-01 | 0.071 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.497992e-01 | 0.071 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.497992e-01 | 0.071 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.497992e-01 | 0.071 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.497992e-01 | 0.071 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.497992e-01 | 0.071 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.540524e-01 | 0.069 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.562860e-01 | 0.067 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.562860e-01 | 0.067 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.562860e-01 | 0.067 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.562860e-01 | 0.067 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.576528e-01 | 0.067 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.582821e-01 | 0.066 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.615957e-01 | 0.065 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.624533e-01 | 0.064 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.624931e-01 | 0.064 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.624931e-01 | 0.064 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 8.624931e-01 | 0.064 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.624931e-01 | 0.064 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.627445e-01 | 0.064 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.671050e-01 | 0.062 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.684325e-01 | 0.061 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.684325e-01 | 0.061 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.684325e-01 | 0.061 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.684325e-01 | 0.061 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.713881e-01 | 0.060 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.741157e-01 | 0.058 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.741157e-01 | 0.058 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.741157e-01 | 0.058 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.741157e-01 | 0.058 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.741157e-01 | 0.058 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.759779e-01 | 0.058 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.775857e-01 | 0.057 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.795537e-01 | 0.056 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.795537e-01 | 0.056 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.795537e-01 | 0.056 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.795537e-01 | 0.056 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.802067e-01 | 0.055 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.802067e-01 | 0.055 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.835277e-01 | 0.054 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.835277e-01 | 0.054 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.847571e-01 | 0.053 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.847571e-01 | 0.053 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.847571e-01 | 0.053 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.847571e-01 | 0.053 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.847571e-01 | 0.053 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.847571e-01 | 0.053 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.847571e-01 | 0.053 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 8.847571e-01 | 0.053 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.847571e-01 | 0.053 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.849896e-01 | 0.053 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.849896e-01 | 0.053 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.868672e-01 | 0.052 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.884149e-01 | 0.051 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.897360e-01 | 0.051 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.897360e-01 | 0.051 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.897360e-01 | 0.051 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.897360e-01 | 0.051 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.897360e-01 | 0.051 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.897360e-01 | 0.051 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.917489e-01 | 0.050 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.945001e-01 | 0.048 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.945001e-01 | 0.048 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.945001e-01 | 0.048 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.945001e-01 | 0.048 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 8.949932e-01 | 0.048 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.990587e-01 | 0.046 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.990587e-01 | 0.046 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.990587e-01 | 0.046 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.990587e-01 | 0.046 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.990587e-01 | 0.046 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.994194e-01 | 0.046 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.024185e-01 | 0.045 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.028576e-01 | 0.044 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.029002e-01 | 0.044 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.034205e-01 | 0.044 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.034205e-01 | 0.044 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.034205e-01 | 0.044 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.034205e-01 | 0.044 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.034205e-01 | 0.044 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.034205e-01 | 0.044 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.075941e-01 | 0.042 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.075941e-01 | 0.042 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.075941e-01 | 0.042 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.075941e-01 | 0.042 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.095271e-01 | 0.041 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.096629e-01 | 0.041 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.099399e-01 | 0.041 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.115876e-01 | 0.040 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.154088e-01 | 0.038 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.154088e-01 | 0.038 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.190650e-01 | 0.037 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.190650e-01 | 0.037 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.190650e-01 | 0.037 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.197266e-01 | 0.036 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.225634e-01 | 0.035 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.225634e-01 | 0.035 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.229311e-01 | 0.035 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.247619e-01 | 0.034 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.252791e-01 | 0.034 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.259108e-01 | 0.033 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.259108e-01 | 0.033 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.259108e-01 | 0.033 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.286440e-01 | 0.032 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.291137e-01 | 0.032 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.320211e-01 | 0.031 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.320211e-01 | 0.031 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.339476e-01 | 0.030 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.344657e-01 | 0.029 | 1 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.351106e-01 | 0.029 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 9.362477e-01 | 0.029 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.362477e-01 | 0.029 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.379163e-01 | 0.028 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.406008e-01 | 0.027 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.406008e-01 | 0.027 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.411762e-01 | 0.026 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.420786e-01 | 0.026 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.431694e-01 | 0.025 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.446385e-01 | 0.025 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.456271e-01 | 0.024 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.456271e-01 | 0.024 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.491520e-01 | 0.023 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.502286e-01 | 0.022 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.502286e-01 | 0.022 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.502286e-01 | 0.022 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.502286e-01 | 0.022 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.502286e-01 | 0.022 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.507099e-01 | 0.022 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 9.509787e-01 | 0.022 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.523814e-01 | 0.021 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.523814e-01 | 0.021 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.544413e-01 | 0.020 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.544413e-01 | 0.020 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.592102e-01 | 0.018 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.592102e-01 | 0.018 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.606895e-01 | 0.017 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.634799e-01 | 0.016 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.634799e-01 | 0.016 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.650602e-01 | 0.015 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.666434e-01 | 0.015 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.672721e-01 | 0.014 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.676826e-01 | 0.014 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.680189e-01 | 0.014 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.680189e-01 | 0.014 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 9.694031e-01 | 0.013 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.694031e-01 | 0.013 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.694031e-01 | 0.013 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.694031e-01 | 0.013 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.694031e-01 | 0.013 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.722683e-01 | 0.012 | 1 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.737153e-01 | 0.012 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.754764e-01 | 0.011 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.765382e-01 | 0.010 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.771339e-01 | 0.010 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.775541e-01 | 0.010 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.775541e-01 | 0.010 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.775541e-01 | 0.010 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.775552e-01 | 0.010 | 0 | 0 |
| Translation | R-HSA-72766 | 9.779558e-01 | 0.010 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.785260e-01 | 0.009 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.791886e-01 | 0.009 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.794559e-01 | 0.009 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.810431e-01 | 0.008 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.811968e-01 | 0.008 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.813365e-01 | 0.008 | 1 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.873782e-01 | 0.006 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.877965e-01 | 0.005 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.889492e-01 | 0.005 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.895631e-01 | 0.005 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.896216e-01 | 0.005 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.906605e-01 | 0.004 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.906605e-01 | 0.004 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.911455e-01 | 0.004 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.917030e-01 | 0.004 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.918967e-01 | 0.004 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.918967e-01 | 0.004 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.925842e-01 | 0.003 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.936773e-01 | 0.003 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.952406e-01 | 0.002 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.953787e-01 | 0.002 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.956447e-01 | 0.002 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.972462e-01 | 0.001 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.978593e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.980412e-01 | 0.001 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.984996e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.985648e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.986343e-01 | 0.001 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.988654e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.991315e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.992633e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.993260e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.994102e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.994483e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.995681e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.998315e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999325e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999419e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999475e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999619e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999740e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999745e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999841e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999884e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999889e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999928e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999967e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999984e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999998e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999998e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.330669e-16 | 15.477 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.331468e-15 | 14.632 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.937295e-14 | 13.049 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.245670e-13 | 12.905 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.725287e-13 | 12.763 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.351586e-13 | 12.197 | 1 | 1 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.523182e-13 | 12.069 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.344924e-12 | 11.871 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.662559e-12 | 11.779 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.834866e-12 | 11.736 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.977285e-12 | 11.526 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.325562e-12 | 11.478 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.671707e-12 | 11.331 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.463319e-12 | 11.350 | 1 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.550116e-12 | 11.256 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 5.327294e-12 | 11.273 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.550116e-12 | 11.256 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.463718e-12 | 11.190 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.428990e-11 | 10.615 | 1 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.130163e-11 | 10.090 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.183776e-11 | 10.037 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 9.183776e-11 | 10.037 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.492462e-11 | 10.023 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.179786e-10 | 9.662 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.216460e-10 | 9.654 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.140491e-10 | 9.669 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.177152e-10 | 9.379 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.197790e-10 | 9.284 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.395264e-09 | 8.855 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.678314e-09 | 8.775 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.781090e-09 | 8.749 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.350293e-09 | 8.629 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.437540e-09 | 8.613 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.116953e-09 | 8.506 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.304766e-09 | 8.136 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 8.415485e-09 | 8.075 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.043262e-08 | 7.982 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.232596e-08 | 7.909 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.587590e-08 | 7.799 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.175820e-08 | 7.498 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.649677e-08 | 7.438 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.755323e-08 | 7.425 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.034063e-08 | 7.298 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.530803e-08 | 7.257 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.129182e-08 | 7.147 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 8.936438e-08 | 7.049 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.175684e-08 | 7.037 | 1 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.078364e-07 | 6.967 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.090670e-07 | 6.962 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.273116e-07 | 6.895 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.428248e-07 | 6.845 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.526627e-07 | 6.816 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.554157e-07 | 6.809 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.770982e-07 | 6.752 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.768141e-07 | 6.558 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.768141e-07 | 6.558 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.517947e-07 | 6.454 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.613559e-07 | 6.442 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.030766e-07 | 6.220 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.595871e-07 | 6.181 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.595871e-07 | 6.181 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.891709e-07 | 6.162 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.891709e-07 | 6.162 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.369418e-06 | 5.863 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.417980e-06 | 5.848 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.417980e-06 | 5.848 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.451567e-06 | 5.838 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.588394e-06 | 5.799 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.606850e-06 | 5.794 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.724136e-06 | 5.763 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.848815e-06 | 5.733 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.282952e-06 | 5.642 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.346529e-06 | 5.630 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.421235e-06 | 5.616 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.421235e-06 | 5.616 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.378298e-06 | 5.471 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 3.384270e-06 | 5.471 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.674555e-06 | 5.435 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.767718e-06 | 5.424 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.010961e-06 | 5.397 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.125119e-06 | 5.385 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.652463e-06 | 5.332 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.156936e-06 | 5.288 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.156936e-06 | 5.288 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.066329e-06 | 5.295 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.139761e-06 | 5.289 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.293638e-06 | 5.201 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.834250e-06 | 5.106 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.890070e-06 | 5.103 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.227242e-06 | 5.035 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.866890e-06 | 5.052 | 1 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.354451e-06 | 5.029 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.007765e-05 | 4.997 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.065877e-05 | 4.972 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.097693e-05 | 4.960 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.165513e-05 | 4.933 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.381253e-05 | 4.860 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.387561e-05 | 4.858 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.508027e-05 | 4.822 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.600844e-05 | 4.796 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.772293e-05 | 4.751 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.940460e-05 | 4.712 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.004857e-05 | 4.698 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.513291e-05 | 4.600 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.513291e-05 | 4.600 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.321229e-05 | 4.634 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.014446e-05 | 4.521 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.041321e-05 | 4.517 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.168157e-05 | 4.499 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.168157e-05 | 4.499 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.512511e-05 | 4.454 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.818515e-05 | 4.418 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.944052e-05 | 4.404 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.944052e-05 | 4.404 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.224247e-05 | 4.374 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.313330e-05 | 4.365 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.368710e-05 | 4.360 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.501532e-05 | 4.347 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.860437e-05 | 4.313 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.243998e-05 | 4.280 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.306941e-05 | 4.275 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.610842e-05 | 4.251 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.855686e-05 | 4.232 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.327327e-05 | 4.199 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.595008e-05 | 4.181 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 7.509940e-05 | 4.124 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.092897e-05 | 4.092 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 8.885346e-05 | 4.051 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.268060e-05 | 4.033 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 9.268060e-05 | 4.033 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 9.551368e-05 | 4.020 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.113883e-04 | 3.953 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.123574e-04 | 3.949 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.180220e-04 | 3.928 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.189048e-04 | 3.925 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.190653e-04 | 3.924 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.207783e-04 | 3.918 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.224371e-04 | 3.912 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.382065e-04 | 3.859 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.411655e-04 | 3.850 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.540093e-04 | 3.812 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.411655e-04 | 3.850 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.564004e-04 | 3.806 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.663394e-04 | 3.779 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.663394e-04 | 3.779 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.711397e-04 | 3.767 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.778320e-04 | 3.750 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.875272e-04 | 3.727 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.881372e-04 | 3.726 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.881372e-04 | 3.726 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.888809e-04 | 3.724 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.027624e-04 | 3.693 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.074125e-04 | 3.683 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.154451e-04 | 3.667 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.195752e-04 | 3.658 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.276834e-04 | 3.643 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.511058e-04 | 3.600 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.565703e-04 | 3.591 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.615788e-04 | 3.582 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.615788e-04 | 3.582 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.681359e-04 | 3.572 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.840423e-04 | 3.547 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.960101e-04 | 3.529 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.974001e-04 | 3.527 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 3.015008e-04 | 3.521 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.039250e-04 | 3.517 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.130415e-04 | 3.504 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.130415e-04 | 3.504 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.364079e-04 | 3.473 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.602676e-04 | 3.443 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.639881e-04 | 3.439 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.691369e-04 | 3.433 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.268250e-04 | 3.370 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.215838e-04 | 3.375 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.173210e-04 | 3.380 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.268250e-04 | 3.370 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.540987e-04 | 3.343 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.375790e-04 | 3.359 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.268250e-04 | 3.370 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.185099e-04 | 3.378 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.820948e-04 | 3.317 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.820948e-04 | 3.317 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.958973e-04 | 3.305 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.964948e-04 | 3.304 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.030362e-04 | 3.298 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.187547e-04 | 3.285 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.204594e-04 | 3.284 | 1 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.766876e-04 | 3.239 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.899107e-04 | 3.229 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.899107e-04 | 3.229 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.899107e-04 | 3.229 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.908722e-04 | 3.229 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.921507e-04 | 3.228 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.283296e-04 | 3.202 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.488092e-04 | 3.188 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.333063e-04 | 3.079 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.333063e-04 | 3.079 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.333063e-04 | 3.079 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.333063e-04 | 3.079 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.434463e-04 | 3.129 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.350458e-04 | 3.134 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.018860e-04 | 3.096 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.921946e-04 | 3.101 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.407576e-04 | 3.075 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.708701e-04 | 3.060 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.875894e-04 | 3.052 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 8.985197e-04 | 3.046 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.985197e-04 | 3.046 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.255176e-04 | 3.034 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.255176e-04 | 3.034 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.255176e-04 | 3.034 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.419181e-04 | 3.026 | 1 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.000554e-03 | 3.000 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.027730e-03 | 2.988 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.057470e-03 | 2.976 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.066349e-03 | 2.972 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.066349e-03 | 2.972 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.201078e-03 | 2.920 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.243359e-03 | 2.905 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.253725e-03 | 2.902 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.253725e-03 | 2.902 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.305581e-03 | 2.884 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.305581e-03 | 2.884 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.473255e-03 | 2.832 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.523282e-03 | 2.817 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.523282e-03 | 2.817 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.399216e-03 | 2.854 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.594038e-03 | 2.798 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.535790e-03 | 2.814 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.444106e-03 | 2.840 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.473212e-03 | 2.832 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.397384e-03 | 2.855 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.492009e-03 | 2.826 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.599260e-03 | 2.796 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.707170e-03 | 2.768 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.710748e-03 | 2.767 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.759266e-03 | 2.755 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.759266e-03 | 2.755 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.759266e-03 | 2.755 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.759266e-03 | 2.755 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.874339e-03 | 2.727 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.876268e-03 | 2.727 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.902424e-03 | 2.721 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.906298e-03 | 2.720 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.042779e-03 | 2.690 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.047829e-03 | 2.689 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.047829e-03 | 2.689 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.081071e-03 | 2.682 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.123555e-03 | 2.673 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.187739e-03 | 2.660 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.187739e-03 | 2.660 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.306480e-03 | 2.637 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.314837e-03 | 2.635 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.349136e-03 | 2.629 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.349136e-03 | 2.629 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.597570e-03 | 2.585 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.597570e-03 | 2.585 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.617081e-03 | 2.582 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.636682e-03 | 2.579 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.689718e-03 | 2.570 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.700444e-03 | 2.569 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.731812e-03 | 2.564 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.825560e-03 | 2.549 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.834677e-03 | 2.547 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 3.712575e-03 | 2.430 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.287516e-03 | 2.483 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.287516e-03 | 2.483 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.066967e-03 | 2.513 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.256419e-03 | 2.487 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.486292e-03 | 2.458 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.575453e-03 | 2.447 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.256419e-03 | 2.487 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.448384e-03 | 2.462 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.540147e-03 | 2.451 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.256419e-03 | 2.487 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.483374e-03 | 2.458 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.060980e-03 | 2.514 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.649900e-03 | 2.438 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.598483e-03 | 2.444 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.483374e-03 | 2.458 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.260859e-03 | 2.487 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.980721e-03 | 2.526 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.730502e-03 | 2.428 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.830150e-03 | 2.417 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.874426e-03 | 2.412 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.914776e-03 | 2.407 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.937955e-03 | 2.405 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.941480e-03 | 2.404 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.961213e-03 | 2.402 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.441855e-03 | 2.352 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.552163e-03 | 2.342 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.601719e-03 | 2.337 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.601719e-03 | 2.337 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.618239e-03 | 2.336 | 1 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.658876e-03 | 2.332 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.716132e-03 | 2.326 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.716132e-03 | 2.326 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.915832e-03 | 2.308 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.923339e-03 | 2.308 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.993137e-03 | 2.302 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.138505e-03 | 2.289 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.186238e-03 | 2.285 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.208929e-03 | 2.283 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.472952e-03 | 2.262 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.492550e-03 | 2.260 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.585565e-03 | 2.253 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.629669e-03 | 2.250 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.686606e-03 | 2.245 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.946415e-03 | 2.226 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.021158e-03 | 2.220 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.021158e-03 | 2.220 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.021158e-03 | 2.220 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.242920e-03 | 2.205 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.568622e-03 | 2.183 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.568622e-03 | 2.183 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 6.757193e-03 | 2.170 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 6.948752e-03 | 2.158 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.267123e-03 | 2.139 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.413776e-03 | 2.130 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 7.881755e-03 | 2.103 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 8.112519e-03 | 2.091 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.140346e-03 | 2.089 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.535635e-03 | 2.069 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.614363e-03 | 2.065 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.688438e-03 | 2.061 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.111797e-03 | 2.040 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.769825e-03 | 2.010 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.011656e-02 | 1.995 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.037386e-02 | 1.984 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.040881e-02 | 1.983 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.041864e-02 | 1.982 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.046647e-02 | 1.980 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.400809e-02 | 1.854 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.400809e-02 | 1.854 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.400809e-02 | 1.854 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.348704e-02 | 1.870 | 1 | 1 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.348704e-02 | 1.870 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.079992e-02 | 1.967 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.281283e-02 | 1.892 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.139491e-02 | 1.943 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.300154e-02 | 1.886 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.079992e-02 | 1.967 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.324867e-02 | 1.878 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.081142e-02 | 1.966 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.204681e-02 | 1.919 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.204681e-02 | 1.919 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.058414e-02 | 1.975 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.364822e-02 | 1.865 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.079992e-02 | 1.967 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.140646e-02 | 1.943 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.139491e-02 | 1.943 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.079992e-02 | 1.967 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.143340e-02 | 1.942 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.416232e-02 | 1.849 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.420323e-02 | 1.848 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.420323e-02 | 1.848 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.488317e-02 | 1.827 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.498735e-02 | 1.824 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.585157e-02 | 1.800 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.586251e-02 | 1.800 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.627183e-02 | 1.789 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.627183e-02 | 1.789 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.687239e-02 | 1.773 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.687239e-02 | 1.773 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.695331e-02 | 1.771 | 1 | 1 |
| Lipophagy | R-HSA-9613354 | 1.695331e-02 | 1.771 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.751985e-02 | 1.756 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.784886e-02 | 1.748 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.807224e-02 | 1.743 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.948304e-02 | 1.710 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.964439e-02 | 1.707 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.022773e-02 | 1.694 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.022773e-02 | 1.694 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.022773e-02 | 1.694 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.087117e-02 | 1.680 | 1 | 1 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.087117e-02 | 1.680 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.087117e-02 | 1.680 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.109951e-02 | 1.676 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.109951e-02 | 1.676 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.126142e-02 | 1.672 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.147345e-02 | 1.668 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.159508e-02 | 1.666 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.191036e-02 | 1.659 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.230412e-02 | 1.652 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.259689e-02 | 1.646 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.317943e-02 | 1.635 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.317943e-02 | 1.635 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.344977e-02 | 1.630 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.524303e-02 | 1.598 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.524303e-02 | 1.598 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.588097e-02 | 1.587 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.596268e-02 | 1.586 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.596268e-02 | 1.586 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.619083e-02 | 1.582 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.637947e-02 | 1.579 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.688155e-02 | 1.571 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.845367e-02 | 1.546 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.974379e-02 | 1.527 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.974379e-02 | 1.527 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.974379e-02 | 1.527 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.974379e-02 | 1.527 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.974379e-02 | 1.527 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.974379e-02 | 1.527 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.983144e-02 | 1.525 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 3.006811e-02 | 1.522 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.041992e-02 | 1.517 | 0 | 0 |
| Translation | R-HSA-72766 | 3.196784e-02 | 1.495 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.268227e-02 | 1.486 | 1 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.268227e-02 | 1.486 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.353801e-02 | 1.474 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.353801e-02 | 1.474 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.353801e-02 | 1.474 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.534288e-02 | 1.452 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.534288e-02 | 1.452 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.565979e-02 | 1.448 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.648551e-02 | 1.438 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.769925e-02 | 1.424 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.872506e-02 | 1.412 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.933506e-02 | 1.405 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.933506e-02 | 1.405 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.933506e-02 | 1.405 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.933506e-02 | 1.405 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.083651e-02 | 1.389 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 4.343166e-02 | 1.362 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 4.343166e-02 | 1.362 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.992318e-02 | 1.302 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.140374e-02 | 1.212 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.078879e-02 | 1.216 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.619905e-02 | 1.335 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.093364e-02 | 1.293 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.116688e-02 | 1.213 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.460896e-02 | 1.351 | 1 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.460896e-02 | 1.351 | 1 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.696255e-02 | 1.328 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.002382e-02 | 1.301 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.140374e-02 | 1.212 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.379515e-02 | 1.269 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.140374e-02 | 1.212 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.832919e-02 | 1.316 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.379515e-02 | 1.269 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.721547e-02 | 1.326 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.619905e-02 | 1.335 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.240996e-02 | 1.281 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.533838e-02 | 1.344 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.992318e-02 | 1.302 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.142619e-02 | 1.383 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.142619e-02 | 1.383 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.832919e-02 | 1.316 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.493387e-02 | 1.260 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.172128e-02 | 1.380 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.172128e-02 | 1.380 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.293517e-02 | 1.367 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.619905e-02 | 1.335 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.619905e-02 | 1.335 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.116688e-02 | 1.213 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.379515e-02 | 1.269 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.133879e-02 | 1.290 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.337707e-02 | 1.273 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.822325e-02 | 1.235 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.924953e-02 | 1.308 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.203561e-02 | 1.207 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.566646e-02 | 1.183 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.818339e-02 | 1.166 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.818339e-02 | 1.166 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.818339e-02 | 1.166 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.842012e-02 | 1.165 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.842012e-02 | 1.165 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.959770e-02 | 1.157 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.967167e-02 | 1.157 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.104425e-02 | 1.148 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.240147e-02 | 1.140 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.240147e-02 | 1.140 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 7.367946e-02 | 1.133 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 7.367946e-02 | 1.133 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 7.367946e-02 | 1.133 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.367946e-02 | 1.133 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.367946e-02 | 1.133 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.367946e-02 | 1.133 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.367946e-02 | 1.133 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.438180e-02 | 1.129 | 1 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.838537e-02 | 1.106 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.838537e-02 | 1.106 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.838799e-02 | 1.106 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.082335e-02 | 1.092 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.110546e-02 | 1.091 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.411770e-02 | 1.075 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.447099e-02 | 1.073 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 8.497953e-02 | 1.071 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 8.497953e-02 | 1.071 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 8.497953e-02 | 1.071 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 8.497953e-02 | 1.071 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 8.497953e-02 | 1.071 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 8.497953e-02 | 1.071 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 8.497953e-02 | 1.071 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 8.497953e-02 | 1.071 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 8.497953e-02 | 1.071 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 8.497953e-02 | 1.071 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 8.497953e-02 | 1.071 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 8.497953e-02 | 1.071 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.639864e-02 | 1.063 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 8.665985e-02 | 1.062 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 8.665985e-02 | 1.062 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 8.665985e-02 | 1.062 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 8.665985e-02 | 1.062 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 8.665985e-02 | 1.062 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.004042e-02 | 1.046 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.255509e-02 | 1.034 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.262625e-02 | 1.033 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 9.262625e-02 | 1.033 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.295055e-02 | 1.032 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.476293e-02 | 1.023 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.489567e-02 | 1.023 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.524190e-02 | 1.021 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 9.774737e-02 | 1.010 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.774737e-02 | 1.010 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 9.774737e-02 | 1.010 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.793010e-02 | 1.009 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.793010e-02 | 1.009 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.868541e-02 | 1.006 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.868541e-02 | 1.006 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.868541e-02 | 1.006 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.987232e-02 | 1.001 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.002607e-01 | 0.999 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.002607e-01 | 0.999 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.002607e-01 | 0.999 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.002607e-01 | 0.999 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.002607e-01 | 0.999 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.002607e-01 | 0.999 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.002607e-01 | 0.999 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 1.002607e-01 | 0.999 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.008771e-01 | 0.996 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.008771e-01 | 0.996 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.014738e-01 | 0.994 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.014738e-01 | 0.994 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.046530e-01 | 0.980 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.046530e-01 | 0.980 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.050143e-01 | 0.979 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.051297e-01 | 0.978 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.247252e-01 | 0.904 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.247252e-01 | 0.904 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.247252e-01 | 0.904 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.247252e-01 | 0.904 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 1.247252e-01 | 0.904 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.247252e-01 | 0.904 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.247252e-01 | 0.904 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.247252e-01 | 0.904 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.627468e-01 | 0.788 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.627468e-01 | 0.788 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.627468e-01 | 0.788 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.627468e-01 | 0.788 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.627468e-01 | 0.788 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.627468e-01 | 0.788 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.627468e-01 | 0.788 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.627468e-01 | 0.788 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.627468e-01 | 0.788 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.627468e-01 | 0.788 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.627468e-01 | 0.788 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.627468e-01 | 0.788 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.627468e-01 | 0.788 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 1.991189e-01 | 0.701 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 1.991189e-01 | 0.701 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.991189e-01 | 0.701 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.991189e-01 | 0.701 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.991189e-01 | 0.701 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.991189e-01 | 0.701 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.144039e-01 | 0.942 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.144039e-01 | 0.942 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.144039e-01 | 0.942 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.144039e-01 | 0.942 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.144039e-01 | 0.942 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.440319e-01 | 0.842 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.440319e-01 | 0.842 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.593871e-01 | 0.798 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.593871e-01 | 0.798 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.750244e-01 | 0.757 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.106431e-01 | 0.956 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.201167e-01 | 0.920 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.069365e-01 | 0.684 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.069365e-01 | 0.684 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.069365e-01 | 0.684 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.069365e-01 | 0.684 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.117743e-01 | 0.952 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.714234e-01 | 0.766 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.314312e-01 | 0.881 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.843704e-01 | 0.734 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.313764e-01 | 0.881 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.422763e-01 | 0.847 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.440319e-01 | 0.842 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.440319e-01 | 0.842 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.144039e-01 | 0.942 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.290167e-01 | 0.889 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.191044e-01 | 0.924 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.934504e-01 | 0.713 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.605828e-01 | 0.794 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.586329e-01 | 0.800 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.164080e-01 | 0.934 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.290167e-01 | 0.889 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.593871e-01 | 0.798 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.843704e-01 | 0.734 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.952087e-01 | 0.710 | 1 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.488653e-01 | 0.827 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.513252e-01 | 0.820 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.750244e-01 | 0.757 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.908907e-01 | 0.719 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.908907e-01 | 0.719 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.069365e-01 | 0.684 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 2.047161e-01 | 0.689 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.728926e-01 | 0.762 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.106431e-01 | 0.956 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.670599e-01 | 0.777 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.047161e-01 | 0.689 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 1.247252e-01 | 0.904 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.247252e-01 | 0.904 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 1.247252e-01 | 0.904 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.627468e-01 | 0.788 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.627468e-01 | 0.788 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.627468e-01 | 0.788 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.991189e-01 | 0.701 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.440319e-01 | 0.842 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.908907e-01 | 0.719 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.069365e-01 | 0.684 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.501848e-01 | 0.823 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.823471e-01 | 0.739 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.952087e-01 | 0.710 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.257836e-01 | 0.900 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 1.422763e-01 | 0.847 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.756419e-01 | 0.755 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.069365e-01 | 0.684 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.001038e-01 | 0.699 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.792423e-01 | 0.747 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.593871e-01 | 0.798 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.144039e-01 | 0.942 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.144039e-01 | 0.942 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.289477e-01 | 0.890 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.585106e-01 | 0.800 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.876408e-01 | 0.727 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.047161e-01 | 0.689 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 2.028810e-01 | 0.693 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.201167e-01 | 0.920 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.142298e-01 | 0.669 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.867199e-01 | 0.729 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.370922e-01 | 0.863 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.288298e-01 | 0.890 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.932373e-01 | 0.714 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.247252e-01 | 0.904 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 1.247252e-01 | 0.904 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.750244e-01 | 0.757 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 1.823471e-01 | 0.739 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.585106e-01 | 0.800 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.113518e-01 | 0.675 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.503690e-01 | 0.823 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.714234e-01 | 0.766 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.735209e-01 | 0.761 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.383378e-01 | 0.859 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.836967e-01 | 0.736 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.144039e-01 | 0.942 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.440319e-01 | 0.842 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.593871e-01 | 0.798 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.201167e-01 | 0.920 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 1.503690e-01 | 0.823 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.047161e-01 | 0.689 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.606967e-01 | 0.794 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.201532e-01 | 0.920 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.069365e-01 | 0.684 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.606967e-01 | 0.794 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.191044e-01 | 0.924 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.503690e-01 | 0.823 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.335527e-01 | 0.874 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.512950e-01 | 0.820 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.201167e-01 | 0.920 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.604584e-01 | 0.795 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.585106e-01 | 0.800 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.331780e-01 | 0.876 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.106431e-01 | 0.956 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.144039e-01 | 0.942 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.908907e-01 | 0.719 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.867199e-01 | 0.729 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.161273e-01 | 0.665 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.161273e-01 | 0.665 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 2.161273e-01 | 0.665 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.180542e-01 | 0.661 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 2.205827e-01 | 0.656 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.205827e-01 | 0.656 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.231164e-01 | 0.651 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.231164e-01 | 0.651 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 2.231164e-01 | 0.651 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.231164e-01 | 0.651 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.231164e-01 | 0.651 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.278651e-01 | 0.642 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 2.339131e-01 | 0.631 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 2.339131e-01 | 0.631 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.339131e-01 | 0.631 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.339131e-01 | 0.631 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.339131e-01 | 0.631 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.339131e-01 | 0.631 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.339131e-01 | 0.631 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.339131e-01 | 0.631 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.349926e-01 | 0.629 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.393209e-01 | 0.621 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.393209e-01 | 0.621 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.393495e-01 | 0.621 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.393886e-01 | 0.621 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.393886e-01 | 0.621 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.393886e-01 | 0.621 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.393886e-01 | 0.621 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.393886e-01 | 0.621 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.393886e-01 | 0.621 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.393886e-01 | 0.621 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.426297e-01 | 0.615 | 1 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.433914e-01 | 0.614 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.488687e-01 | 0.604 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.494476e-01 | 0.603 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.510715e-01 | 0.600 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.510715e-01 | 0.600 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.510715e-01 | 0.600 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 2.520122e-01 | 0.599 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.528729e-01 | 0.597 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.530239e-01 | 0.597 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.557147e-01 | 0.592 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.557147e-01 | 0.592 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.654445e-01 | 0.576 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.671976e-01 | 0.573 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.671976e-01 | 0.573 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.671976e-01 | 0.573 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.671976e-01 | 0.573 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.671976e-01 | 0.573 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 2.671976e-01 | 0.573 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 2.671976e-01 | 0.573 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 2.681378e-01 | 0.572 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.720592e-01 | 0.565 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.720592e-01 | 0.565 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.722901e-01 | 0.565 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.748044e-01 | 0.561 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 2.748044e-01 | 0.561 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.778714e-01 | 0.556 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 2.867576e-01 | 0.542 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 2.867576e-01 | 0.542 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.868184e-01 | 0.542 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.876605e-01 | 0.541 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.883898e-01 | 0.540 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.883898e-01 | 0.540 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 2.883898e-01 | 0.540 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.883898e-01 | 0.540 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.927039e-01 | 0.534 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.937054e-01 | 0.532 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.941581e-01 | 0.531 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.990380e-01 | 0.524 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.990380e-01 | 0.524 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.990380e-01 | 0.524 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.990380e-01 | 0.524 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.990380e-01 | 0.524 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.990380e-01 | 0.524 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.990380e-01 | 0.524 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 2.990380e-01 | 0.524 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 2.990380e-01 | 0.524 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.990380e-01 | 0.524 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.990380e-01 | 0.524 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.990380e-01 | 0.524 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.012300e-01 | 0.521 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.012300e-01 | 0.521 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.046770e-01 | 0.516 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.046770e-01 | 0.516 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.046770e-01 | 0.516 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.073742e-01 | 0.512 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.170942e-01 | 0.499 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.199106e-01 | 0.495 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.208938e-01 | 0.494 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.208938e-01 | 0.494 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.208938e-01 | 0.494 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.215920e-01 | 0.493 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.272185e-01 | 0.485 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.272185e-01 | 0.485 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.294967e-01 | 0.482 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.294967e-01 | 0.482 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.294967e-01 | 0.482 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.294967e-01 | 0.482 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.294967e-01 | 0.482 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.294967e-01 | 0.482 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.325453e-01 | 0.478 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.348353e-01 | 0.475 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 3.348353e-01 | 0.475 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.348353e-01 | 0.475 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.348353e-01 | 0.475 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.370155e-01 | 0.472 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.370155e-01 | 0.472 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 3.370155e-01 | 0.472 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.427886e-01 | 0.465 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.468586e-01 | 0.460 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.468586e-01 | 0.460 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.471354e-01 | 0.460 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.480651e-01 | 0.458 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.530181e-01 | 0.452 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.530198e-01 | 0.452 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.530198e-01 | 0.452 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.530198e-01 | 0.452 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.530198e-01 | 0.452 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.530198e-01 | 0.452 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.530198e-01 | 0.452 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.558546e-01 | 0.449 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.558546e-01 | 0.449 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.558546e-01 | 0.449 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.558546e-01 | 0.449 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.586337e-01 | 0.445 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.586337e-01 | 0.445 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.586337e-01 | 0.445 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.586337e-01 | 0.445 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.586337e-01 | 0.445 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.586337e-01 | 0.445 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 3.586337e-01 | 0.445 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.586337e-01 | 0.445 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.586337e-01 | 0.445 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.586337e-01 | 0.445 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.586337e-01 | 0.445 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.586337e-01 | 0.445 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.586337e-01 | 0.445 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 3.586337e-01 | 0.445 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.586337e-01 | 0.445 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.586337e-01 | 0.445 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.588605e-01 | 0.445 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.588605e-01 | 0.445 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.670700e-01 | 0.435 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.688867e-01 | 0.433 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.688867e-01 | 0.433 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.708303e-01 | 0.431 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.770243e-01 | 0.424 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.784455e-01 | 0.422 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.784455e-01 | 0.422 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 3.845977e-01 | 0.415 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.845977e-01 | 0.415 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.845977e-01 | 0.415 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.865063e-01 | 0.413 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.865063e-01 | 0.413 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 3.865063e-01 | 0.413 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.865063e-01 | 0.413 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.865063e-01 | 0.413 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.865063e-01 | 0.413 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.865063e-01 | 0.413 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.865063e-01 | 0.413 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.865063e-01 | 0.413 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.865063e-01 | 0.413 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.865063e-01 | 0.413 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.903052e-01 | 0.409 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.946336e-01 | 0.404 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.946336e-01 | 0.404 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.946336e-01 | 0.404 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.968925e-01 | 0.401 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.968925e-01 | 0.401 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.968925e-01 | 0.401 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.999267e-01 | 0.398 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.999267e-01 | 0.398 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.001365e-01 | 0.398 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.001365e-01 | 0.398 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.001365e-01 | 0.398 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.001365e-01 | 0.398 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 4.001365e-01 | 0.398 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.027316e-01 | 0.395 | 1 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.034123e-01 | 0.394 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.064486e-01 | 0.391 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.064486e-01 | 0.391 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.064486e-01 | 0.391 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.067880e-01 | 0.391 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 4.131691e-01 | 0.384 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.131691e-01 | 0.384 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.131691e-01 | 0.384 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.131691e-01 | 0.384 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.131691e-01 | 0.384 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 4.131691e-01 | 0.384 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.131691e-01 | 0.384 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 4.131691e-01 | 0.384 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.131691e-01 | 0.384 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.131691e-01 | 0.384 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.131691e-01 | 0.384 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.138268e-01 | 0.383 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.154885e-01 | 0.381 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.154885e-01 | 0.381 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.154885e-01 | 0.381 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.154885e-01 | 0.381 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.154885e-01 | 0.381 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.183358e-01 | 0.378 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.338898e-01 | 0.363 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.386747e-01 | 0.358 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.386747e-01 | 0.358 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 4.386747e-01 | 0.358 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.386747e-01 | 0.358 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.386747e-01 | 0.358 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.386747e-01 | 0.358 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.386747e-01 | 0.358 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.386747e-01 | 0.358 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.386747e-01 | 0.358 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 4.386747e-01 | 0.358 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.386747e-01 | 0.358 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.434213e-01 | 0.353 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.455811e-01 | 0.351 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.455811e-01 | 0.351 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.455811e-01 | 0.351 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.455811e-01 | 0.351 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 4.542057e-01 | 0.343 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.556780e-01 | 0.341 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.570779e-01 | 0.340 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.630733e-01 | 0.334 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.630733e-01 | 0.334 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.630733e-01 | 0.334 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.630733e-01 | 0.334 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.630733e-01 | 0.334 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.630733e-01 | 0.334 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 4.630733e-01 | 0.334 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.630733e-01 | 0.334 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.630733e-01 | 0.334 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.630733e-01 | 0.334 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 4.630733e-01 | 0.334 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.630733e-01 | 0.334 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.630733e-01 | 0.334 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.630733e-01 | 0.334 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.643270e-01 | 0.333 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.747879e-01 | 0.324 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.747879e-01 | 0.324 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.747879e-01 | 0.324 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.747879e-01 | 0.324 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.756132e-01 | 0.323 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.756132e-01 | 0.323 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.864128e-01 | 0.313 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 4.864128e-01 | 0.313 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.864128e-01 | 0.313 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.864128e-01 | 0.313 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.864128e-01 | 0.313 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.864128e-01 | 0.313 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.864128e-01 | 0.313 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.864128e-01 | 0.313 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.864128e-01 | 0.313 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 4.864128e-01 | 0.313 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.864128e-01 | 0.313 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.864128e-01 | 0.313 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.890375e-01 | 0.311 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 4.890375e-01 | 0.311 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.937966e-01 | 0.306 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.937966e-01 | 0.306 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.978472e-01 | 0.303 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.978472e-01 | 0.303 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.978472e-01 | 0.303 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.978472e-01 | 0.303 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.087390e-01 | 0.294 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.087390e-01 | 0.294 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.087390e-01 | 0.294 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.087390e-01 | 0.294 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.087390e-01 | 0.294 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.087390e-01 | 0.294 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.087390e-01 | 0.294 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.087390e-01 | 0.294 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.087390e-01 | 0.294 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.087390e-01 | 0.294 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.087390e-01 | 0.294 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.087390e-01 | 0.294 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.087390e-01 | 0.294 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.087390e-01 | 0.294 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 5.087390e-01 | 0.294 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.087390e-01 | 0.294 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.087390e-01 | 0.294 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.087390e-01 | 0.294 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.087390e-01 | 0.294 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.087844e-01 | 0.293 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 5.087844e-01 | 0.293 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.087844e-01 | 0.293 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 5.087844e-01 | 0.293 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.167959e-01 | 0.287 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.167959e-01 | 0.287 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.167959e-01 | 0.287 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.167959e-01 | 0.287 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.167959e-01 | 0.287 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.167959e-01 | 0.287 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.167959e-01 | 0.287 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.300961e-01 | 0.276 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 5.300961e-01 | 0.276 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.300961e-01 | 0.276 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.300961e-01 | 0.276 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.300961e-01 | 0.276 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.300961e-01 | 0.276 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.300961e-01 | 0.276 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.302764e-01 | 0.275 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.302944e-01 | 0.275 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.302944e-01 | 0.275 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.314741e-01 | 0.275 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.394987e-01 | 0.268 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.408231e-01 | 0.267 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.408231e-01 | 0.267 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.435338e-01 | 0.265 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 5.466803e-01 | 0.262 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 5.466803e-01 | 0.262 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 5.466803e-01 | 0.262 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.505259e-01 | 0.259 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 5.505259e-01 | 0.259 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.505259e-01 | 0.259 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.505259e-01 | 0.259 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.505259e-01 | 0.259 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.505259e-01 | 0.259 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.505259e-01 | 0.259 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.505259e-01 | 0.259 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.505259e-01 | 0.259 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 5.505259e-01 | 0.259 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.505259e-01 | 0.259 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.505259e-01 | 0.259 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.565110e-01 | 0.255 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.615003e-01 | 0.251 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.692240e-01 | 0.245 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.692240e-01 | 0.245 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.692240e-01 | 0.245 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.692240e-01 | 0.245 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 5.692240e-01 | 0.245 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.700686e-01 | 0.244 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.700686e-01 | 0.244 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 5.700686e-01 | 0.244 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.700686e-01 | 0.244 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.700686e-01 | 0.244 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.700686e-01 | 0.244 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.700686e-01 | 0.244 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.700686e-01 | 0.244 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.700686e-01 | 0.244 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.700686e-01 | 0.244 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.716248e-01 | 0.243 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.716248e-01 | 0.243 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.774842e-01 | 0.238 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.887628e-01 | 0.230 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.887628e-01 | 0.230 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.887628e-01 | 0.230 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.887628e-01 | 0.230 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.887628e-01 | 0.230 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.920024e-01 | 0.228 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.938512e-01 | 0.226 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 5.946211e-01 | 0.226 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.011123e-01 | 0.221 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.011123e-01 | 0.221 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.011123e-01 | 0.221 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.013673e-01 | 0.221 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.057643e-01 | 0.218 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.066453e-01 | 0.217 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.066453e-01 | 0.217 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.086142e-01 | 0.216 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.159034e-01 | 0.210 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.174104e-01 | 0.209 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.174104e-01 | 0.209 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.174104e-01 | 0.209 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.174104e-01 | 0.209 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.174104e-01 | 0.209 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.174104e-01 | 0.209 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.174104e-01 | 0.209 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.237511e-01 | 0.205 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 6.237511e-01 | 0.205 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.237511e-01 | 0.205 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.237511e-01 | 0.205 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.237511e-01 | 0.205 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.237511e-01 | 0.205 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.237511e-01 | 0.205 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 6.287902e-01 | 0.201 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.287902e-01 | 0.201 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.287902e-01 | 0.201 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.327393e-01 | 0.199 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 6.355396e-01 | 0.197 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.358905e-01 | 0.197 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.399050e-01 | 0.194 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.401141e-01 | 0.194 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.401141e-01 | 0.194 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.401141e-01 | 0.194 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.401141e-01 | 0.194 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.401141e-01 | 0.194 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.401141e-01 | 0.194 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.401141e-01 | 0.194 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.401141e-01 | 0.194 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.401141e-01 | 0.194 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.401141e-01 | 0.194 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.401141e-01 | 0.194 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.507561e-01 | 0.187 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 6.507561e-01 | 0.187 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.557664e-01 | 0.183 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.557664e-01 | 0.183 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 6.557664e-01 | 0.183 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.557664e-01 | 0.183 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.557664e-01 | 0.183 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 6.557664e-01 | 0.183 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.557664e-01 | 0.183 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 6.557664e-01 | 0.183 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.633799e-01 | 0.178 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.647008e-01 | 0.177 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.707389e-01 | 0.173 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 6.707389e-01 | 0.173 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.707389e-01 | 0.173 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.707389e-01 | 0.173 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.707389e-01 | 0.173 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.707389e-01 | 0.173 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.707389e-01 | 0.173 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.707389e-01 | 0.173 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.716755e-01 | 0.173 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.729844e-01 | 0.172 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.732965e-01 | 0.172 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.778759e-01 | 0.169 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.812639e-01 | 0.167 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.812639e-01 | 0.167 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.812639e-01 | 0.167 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 6.812639e-01 | 0.167 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.817485e-01 | 0.166 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.849300e-01 | 0.164 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.849300e-01 | 0.164 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.850610e-01 | 0.164 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.850610e-01 | 0.164 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.850610e-01 | 0.164 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.850610e-01 | 0.164 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.850610e-01 | 0.164 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.850610e-01 | 0.164 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.850610e-01 | 0.164 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 6.850610e-01 | 0.164 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.915673e-01 | 0.160 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.915673e-01 | 0.160 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.915673e-01 | 0.160 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.915673e-01 | 0.160 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.915673e-01 | 0.160 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.973529e-01 | 0.157 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.987609e-01 | 0.156 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.987609e-01 | 0.156 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.987609e-01 | 0.156 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.987609e-01 | 0.156 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.987609e-01 | 0.156 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.011351e-01 | 0.154 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.045710e-01 | 0.152 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.104550e-01 | 0.148 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.118657e-01 | 0.148 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.118657e-01 | 0.148 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.118657e-01 | 0.148 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.118657e-01 | 0.148 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.118657e-01 | 0.148 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.118657e-01 | 0.148 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.118657e-01 | 0.148 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.118657e-01 | 0.148 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.128190e-01 | 0.147 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.195305e-01 | 0.143 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.195305e-01 | 0.143 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.203204e-01 | 0.142 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.244012e-01 | 0.140 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.244012e-01 | 0.140 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.244012e-01 | 0.140 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.244012e-01 | 0.140 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.276685e-01 | 0.138 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.363920e-01 | 0.133 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.363920e-01 | 0.133 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 7.363920e-01 | 0.133 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.363920e-01 | 0.133 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.363920e-01 | 0.133 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.363920e-01 | 0.133 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.363920e-01 | 0.133 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.363920e-01 | 0.133 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.385410e-01 | 0.132 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.440469e-01 | 0.128 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.453276e-01 | 0.128 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.453276e-01 | 0.128 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.478619e-01 | 0.126 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.478619e-01 | 0.126 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.478619e-01 | 0.126 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.478619e-01 | 0.126 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.478619e-01 | 0.126 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.478619e-01 | 0.126 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.478619e-01 | 0.126 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.478619e-01 | 0.126 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.495325e-01 | 0.125 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.534630e-01 | 0.123 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.588333e-01 | 0.120 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.588333e-01 | 0.120 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.588333e-01 | 0.120 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.588333e-01 | 0.120 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.588333e-01 | 0.120 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.588333e-01 | 0.120 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.588333e-01 | 0.120 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.588333e-01 | 0.120 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.613735e-01 | 0.118 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.652567e-01 | 0.116 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.680317e-01 | 0.115 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.690630e-01 | 0.114 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.693280e-01 | 0.114 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.693280e-01 | 0.114 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.693280e-01 | 0.114 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.693280e-01 | 0.114 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.693280e-01 | 0.114 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.693280e-01 | 0.114 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.693280e-01 | 0.114 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.693280e-01 | 0.114 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.693280e-01 | 0.114 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.791264e-01 | 0.108 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.793666e-01 | 0.108 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.793666e-01 | 0.108 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.793666e-01 | 0.108 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.793666e-01 | 0.108 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.793666e-01 | 0.108 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.793666e-01 | 0.108 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.806181e-01 | 0.108 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.871197e-01 | 0.104 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.889689e-01 | 0.103 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.889689e-01 | 0.103 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.889689e-01 | 0.103 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.908490e-01 | 0.102 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.908490e-01 | 0.102 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 7.930113e-01 | 0.101 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.976979e-01 | 0.098 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.981538e-01 | 0.098 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.981538e-01 | 0.098 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.981538e-01 | 0.098 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.987665e-01 | 0.098 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.043474e-01 | 0.095 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.069395e-01 | 0.093 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.069395e-01 | 0.093 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.069395e-01 | 0.093 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.152329e-01 | 0.089 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.153434e-01 | 0.089 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.153434e-01 | 0.089 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 8.153434e-01 | 0.089 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.231436e-01 | 0.085 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.231436e-01 | 0.085 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.231436e-01 | 0.085 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.233819e-01 | 0.084 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.233819e-01 | 0.084 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.290394e-01 | 0.081 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.305426e-01 | 0.081 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.310709e-01 | 0.080 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.310709e-01 | 0.080 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.310709e-01 | 0.080 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.310709e-01 | 0.080 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.374671e-01 | 0.077 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.384256e-01 | 0.077 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.384256e-01 | 0.077 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.384256e-01 | 0.077 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.384256e-01 | 0.077 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.384256e-01 | 0.077 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.384256e-01 | 0.077 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.401337e-01 | 0.076 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.454606e-01 | 0.073 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.508891e-01 | 0.070 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.508891e-01 | 0.070 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.521897e-01 | 0.069 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.536395e-01 | 0.069 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.536395e-01 | 0.069 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.538536e-01 | 0.069 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.538536e-01 | 0.069 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.586261e-01 | 0.066 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.586261e-01 | 0.066 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.586261e-01 | 0.066 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.608329e-01 | 0.065 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.620806e-01 | 0.064 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.647827e-01 | 0.063 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.647827e-01 | 0.063 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.655739e-01 | 0.063 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.700914e-01 | 0.060 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.706715e-01 | 0.060 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.706715e-01 | 0.060 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.763042e-01 | 0.057 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.763042e-01 | 0.057 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.763042e-01 | 0.057 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.763042e-01 | 0.057 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.763042e-01 | 0.057 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.763042e-01 | 0.057 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.816919e-01 | 0.055 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 8.830915e-01 | 0.054 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.830915e-01 | 0.054 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.868452e-01 | 0.052 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.868452e-01 | 0.052 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.868452e-01 | 0.052 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.868452e-01 | 0.052 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.868452e-01 | 0.052 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.868452e-01 | 0.052 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.868452e-01 | 0.052 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.871285e-01 | 0.052 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.883456e-01 | 0.051 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.905666e-01 | 0.050 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.917744e-01 | 0.050 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.948175e-01 | 0.048 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.948175e-01 | 0.048 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 8.948175e-01 | 0.048 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.964891e-01 | 0.047 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.964891e-01 | 0.047 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.984768e-01 | 0.046 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.009987e-01 | 0.045 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.009987e-01 | 0.045 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.009987e-01 | 0.045 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.053121e-01 | 0.043 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.053121e-01 | 0.043 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.053121e-01 | 0.043 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.053121e-01 | 0.043 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.053121e-01 | 0.043 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.053121e-01 | 0.043 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.078688e-01 | 0.042 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.094379e-01 | 0.041 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.119588e-01 | 0.040 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.133841e-01 | 0.039 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.171586e-01 | 0.038 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.171586e-01 | 0.038 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 9.207688e-01 | 0.036 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.207688e-01 | 0.036 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.242219e-01 | 0.034 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.242219e-01 | 0.034 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.275247e-01 | 0.033 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.275247e-01 | 0.033 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.306837e-01 | 0.031 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.337052e-01 | 0.030 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.340390e-01 | 0.030 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.344423e-01 | 0.029 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.346922e-01 | 0.029 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.382464e-01 | 0.028 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.384036e-01 | 0.028 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.385230e-01 | 0.028 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.393594e-01 | 0.027 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.420033e-01 | 0.026 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.430050e-01 | 0.025 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.430050e-01 | 0.025 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.442056e-01 | 0.025 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.450584e-01 | 0.025 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.470413e-01 | 0.024 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.484158e-01 | 0.023 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.492639e-01 | 0.023 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.492639e-01 | 0.023 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.514069e-01 | 0.022 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.514765e-01 | 0.022 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.514765e-01 | 0.022 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.514765e-01 | 0.022 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.514765e-01 | 0.022 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.514765e-01 | 0.022 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.514765e-01 | 0.022 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.535927e-01 | 0.021 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.535927e-01 | 0.021 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.556167e-01 | 0.020 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.559743e-01 | 0.020 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.575526e-01 | 0.019 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.598122e-01 | 0.018 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.606219e-01 | 0.017 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.644887e-01 | 0.016 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.660381e-01 | 0.015 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.686280e-01 | 0.014 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.687563e-01 | 0.014 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 9.689372e-01 | 0.014 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.702927e-01 | 0.013 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.702927e-01 | 0.013 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 9.715892e-01 | 0.013 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.719075e-01 | 0.012 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.728292e-01 | 0.012 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.739535e-01 | 0.011 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.782638e-01 | 0.010 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.782638e-01 | 0.010 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.784586e-01 | 0.009 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.784586e-01 | 0.009 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.809193e-01 | 0.008 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.833720e-01 | 0.007 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.850331e-01 | 0.007 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.859887e-01 | 0.006 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.896361e-01 | 0.005 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.914927e-01 | 0.004 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.914927e-01 | 0.004 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.918139e-01 | 0.004 | 1 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.922203e-01 | 0.003 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.924413e-01 | 0.003 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.931968e-01 | 0.003 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.932104e-01 | 0.003 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.937788e-01 | 0.003 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.940080e-01 | 0.003 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.941085e-01 | 0.003 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.943767e-01 | 0.002 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.952714e-01 | 0.002 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.954512e-01 | 0.002 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.968810e-01 | 0.001 | 1 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.973932e-01 | 0.001 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.974313e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.980331e-01 | 0.001 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.988355e-01 | 0.001 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.989261e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.990078e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.991638e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.994624e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.994937e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.995283e-01 | 0.000 | 1 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.995607e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.998484e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.998494e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999195e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999465e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999511e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999762e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999915e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999945e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999984e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999985e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999986e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999991e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999996e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |